
<html lang="en"     class="pb-page"  data-request-id="06e6b2f9-322a-474e-abd8-66131de439ac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2012.55.issue-7;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm201386u;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor" /></meta><meta name="dc.Creator" content="Heather J.  Finlay" /></meta><meta name="dc.Creator" content="John  Lloyd" /></meta><meta name="dc.Creator" content="Wayne  Vaccaro" /></meta><meta name="dc.Creator" content="Alexander  Kover" /></meta><meta name="dc.Creator" content="Lin  Yan" /></meta><meta name="dc.Creator" content="Gauri  Bhave" /></meta><meta name="dc.Creator" content="Joseph  Prol" /></meta><meta name="dc.Creator" content="Tram  Huynh" /></meta><meta name="dc.Creator" content="Rao  Bhandaru" /></meta><meta name="dc.Creator" content="Yolanda  Caringal" /></meta><meta name="dc.Creator" content="John  DiMarco" /></meta><meta name="dc.Creator" content="Jinping  Gan" /></meta><meta name="dc.Creator" content="Tim  Harper" /></meta><meta name="dc.Creator" content="Christine  Huang" /></meta><meta name="dc.Creator" content="Mary Lee  Conder" /></meta><meta name="dc.Creator" content="Huabin  Sun" /></meta><meta name="dc.Creator" content="Paul  Levesque" /></meta><meta name="dc.Creator" content="Michael  Blanar" /></meta><meta name="dc.Creator" content="Karnail  Atwal" /></meta><meta name="dc.Creator" content="Ruth  Wexler" /></meta><meta name="dc.Description" content="Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current. A potential liability with this chemotype is the formation of a reactive metabolite which demonstr..." /></meta><meta name="Description" content="Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current. A potential liability with this chemotype is the formation of a reactive metabolite which demonstr..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 21, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm201386u" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm201386u" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm201386u" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm201386u" /></link>
        
    
    

<title>Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm201386u" /></meta><meta property="og:title" content="Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0011.jpeg" /></meta><meta property="og:description" content="Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current. A potential liability with this chemotype is the formation of a reactive metabolite which demonstrated covalent binding to protein in vitro. When substituted at the 2 or 3 position, this template yielded potent IKur inhibitors, with selectivity over hERG which did not form reactive metabolites. Subsequent optimization for potency and PK properties lead to the discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (13j), with an acceptable PK profile in preclinical species and potent efficacy in the preclinical rabbit atrial effective refractory period (AERP) model." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm201386u"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm201386u">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm201386u&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm201386u&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm201386u&amp;href=/doi/10.1021/jm201386u" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3036-3048</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm201402v" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm2014666" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="article_relation"><span class="article_relation-correction"><i class="icon-asterisk"></i><span class="relation-text"><a href="/doi/10.1021/jm4010576"><span class="relation-type">ADDITION / CORRECTION</span><span class="relation-desc">This article has been corrected. View the notice.</span></a></span></span></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of ((<i>S</i>)-5-(Methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective I<sub>Kur</sub> Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Heather+J.++Finlay">Heather J. Finlay</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Lloyd">John Lloyd</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wayne++Vaccaro">Wayne Vaccaro</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander++Kover">Alexander Kover</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lin++Yan">Lin Yan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gauri++Bhave">Gauri Bhave</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph++Prol">Joseph Prol</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tram++Huynh">Tram Huynh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rao++Bhandaru">Rao Bhandaru</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yolanda++Caringal">Yolanda Caringal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++DiMarco">John DiMarco</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jinping++Gan">Jinping Gan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tim++Harper">Tim Harper</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Huang">Christine Huang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary+Lee++Conder">Mary Lee Conder</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Huabin++Sun">Huabin Sun</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Levesque">Paul Levesque</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Blanar">Michael Blanar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Karnail++Atwal">Karnail Atwal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ruth++Wexler">Ruth Wexler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>â </sup>Departments of Discovery Chemistry, <sup>â¡</sup>Crystallography, <sup>Â§</sup>Biology and <sup>â¥</sup>Preclinical Candidate Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey 08543-5400, United States</span></div><div class="corresp-info"><strong>*</strong>For H.J.F.: phone, 609-818-3734; fax, 609-818-3550; E-mail, <a href="/cdn-cgi/l/email-protection#7c14191d0814190e521a1512101d053c1e110f521f1311"><span class="__cf_email__" data-cfemail="f49c9195809c9186da929d9a98958db4969987da979b99">[emailÂ protected]</span></a>. For J.L.: phone, 609-818-5327; fax, 609-818-3550; E-mail, <a href="/cdn-cgi/l/email-protection#0d676265632361616274694d6f607e236e6260"><span class="__cf_email__" data-cfemail="b5dfdadddb9bd9d9daccd1f5d7d8c69bd6dad8">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm201386u&amp;href=/doi/10.1021%2Fjm201386u" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3036â3048</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 12, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>26 October 2011</li><li><span class="item_label"><b>Published</b> online</span>21 March 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 April 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm201386u" title="DOI URL">https://doi.org/10.1021/jm201386u</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3036%26pageCount%3D13%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DHeather%2BJ.%2BFinlay%252C%2BJohn%2BLloyd%252C%2BWayne%2BVaccaro%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D7%26contentID%3Djm201386u%26title%3DDiscovery%2Bof%2B%2528%2528S%2529-5-%2528Methoxymethyl%2529-7-%25281-methyl-1H-indol-2-yl%2529-2-%2528trifluoromethyl%2529-4%252C7-dihydropyrazolo%255B1%252C5-a%255Dpyrimidin-6-yl%2529%2528%2528S%2529-2-%25283-methylisoxazol-5-yl%2529pyrrolidin-1-yl%2529methanone%2BAs%2Ba%2BPotent%2Band%2BSelective%2BIKur%2BInhibitor%26numPages%3D13%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3048%26publicationDate%3DApril%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm201386u"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3059</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm201386u" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of ((S)-5-(Methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone As a Potent and Selective IKur Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Heather&quot;,&quot;last_name&quot;:&quot;J. Finlay&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Lloyd&quot;},{&quot;first_name&quot;:&quot;Wayne&quot;,&quot;last_name&quot;:&quot;Vaccaro&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;Kover&quot;},{&quot;first_name&quot;:&quot;Lin&quot;,&quot;last_name&quot;:&quot;Yan&quot;},{&quot;first_name&quot;:&quot;Gauri&quot;,&quot;last_name&quot;:&quot;Bhave&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;Prol&quot;},{&quot;first_name&quot;:&quot;Tram&quot;,&quot;last_name&quot;:&quot;Huynh&quot;},{&quot;first_name&quot;:&quot;Rao&quot;,&quot;last_name&quot;:&quot;Bhandaru&quot;},{&quot;first_name&quot;:&quot;Yolanda&quot;,&quot;last_name&quot;:&quot;Caringal&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;DiMarco&quot;},{&quot;first_name&quot;:&quot;Jinping&quot;,&quot;last_name&quot;:&quot;Gan&quot;},{&quot;first_name&quot;:&quot;Tim&quot;,&quot;last_name&quot;:&quot;Harper&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Huang&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;Lee Conder&quot;},{&quot;first_name&quot;:&quot;Huabin&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Levesque&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Blanar&quot;},{&quot;first_name&quot;:&quot;Karnail&quot;,&quot;last_name&quot;:&quot;Atwal&quot;},{&quot;first_name&quot;:&quot;Ruth&quot;,&quot;last_name&quot;:&quot;Wexler&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;21&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;3036-3048&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm201386u&quot;},&quot;abstract&quot;:&quot;Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of IKur current. A potential liability with this chemotype is the formation of a reactive metabolite which demonstrated covalent binding to protein in vitro. When substituted at the 2 or 3 position, this template yielded potent IKur inhibitors, with selectivity over hERG which did not form reactive metabolites. Subsequent optimization for potency and PK properties lead to the discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (13j), with an acceptable PK profile in preclinical species and potent efficacy in the preclinical rabbit atrial effective refractory period (AERP) model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201386u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201386u" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201386u&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201386u" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm201386u&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201386u" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm201386u&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm201386u&amp;href=/doi/10.1021/jm201386u" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm201386u" /></input><a href="/doi/pdf/10.1021/jm201386u" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (817 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm201386u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm201386u%26sid%3Dliteratum%253Aachs%26pmid%3D22409629%26genre%3Darticle%26aulast%3DFinlay%26date%3D2012%26atitle%3DDiscovery%2Bof%2B%2528%2528S%2529-5-%2528Methoxymethyl%2529-7-%25281-methyl-1H-indol-2-yl%2529-2-%2528trifluoromethyl%2529-4%252C7-dihydropyrazolo%255B1%252C5-a%255Dpyrimidin-6-yl%2529%2528%2528S%2529-2-%25283-methylisoxazol-5-yl%2529pyrrolidin-1-yl%2529methanone%2BAs%2Ba%2BPotent%2Band%2BSelective%2BIKur%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D7%26spage%3D3036%26epage%3D3048%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290658" title="Amides">Amides</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jmcmar.2012.55.issue-7/production/jmcmar.2012.55.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Previously disclosed dihydropyrazolopyrimidines are potent and selective blockers of I<sub>Kur</sub> current. A potential liability with this chemotype is the formation of a reactive metabolite which demonstrated covalent binding to protein in vitro. When substituted at the 2 or 3 position, this template yielded potent I<sub>Kur</sub> inhibitors, with selectivity over <i>h</i>ERG which did not form reactive metabolites. Subsequent optimization for potency and PK properties lead to the discovery of ((<i>S</i>)-5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13j</b>), with an acceptable PK profile in preclinical species and potent efficacy in the preclinical rabbit atrial effective refractory period (AERP) model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>â¥</span>Â Author Status</h4><p class="last">Deceased December 29, 2006.</p></div><div class="extra-info-sec articleNote"><h4><span>#</span>Â Author Status</h4><p class="last">Deceased September 16, 2008.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51343" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51343" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Atrial fibrillation (AF) is a condition in which the normal heart rhythm is disrupted by rapid activity in areas of the atria. AF is the most common form of sustained cardiac arrhythmia, and the prevalence is increasing as the population continues to age.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> AF is projected to affect an estimated 5.6 million patients in the US by 2050.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In addition to significantly affecting quality of life, AF is also associated with a 3-fold higher incidence of stroke and a 2-fold increase in mortality.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Current therapies for treatment of AF include antithrombotic, rate control, or rhythm control. The termination of AF and restoring of normal sinus rhythm (rhythm control) is typically achieved with antiarrhythmic drugs.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Currently available antiarrhythmic drugs target ion channels which are expressed in the human atrium and ventricle, for example, amiodarone/dronedarone,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> dofetilide,<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> flecainide,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and sotalol.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Inhibition of ventricular ion channels can lead to prolongation of ventricular effective refractory period and the potentially life threatening arrhythmia torsades de pointe.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Initial administration of nonselective rhythm control drugs is, therefore, often limited to a hospital setting where monitoring of ventricular effects are required. Thus, there is currently an unmet medical need for safe and efficacious treatment of AF.</div><div class="NLM_p">I<sub>Kur</sub> is a delayed rectifier repolarization potassium current encoded by the K<sub>v</sub>1.5 gene in humans<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which is functionally expressed in the human atrium and not in the ventricle. Selective inhibition of I<sub>Kur</sub> leads to a prolongation in effective refractory period and should terminate AF without being pro-arrhythmic in the ventricle, leading to a potentially safer treatment for patients with AF.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">We have disclosed dihydropyrazolopyrimidines <b>1</b>, <b>2</b>, and <b>3</b> as potent and selective blockers of I<sub>Kur</sub> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref12 ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref12 ref13 ref14">(12-14)</a> Substitution at C7 indicated that a 2,3-dichloro or 3,4-dichloro aryl group was preferred to maintain potency and selectivity for K<sub>v</sub>1.5. Metabolite identification studies on compounds <b>1</b> and <b>2</b> established the major routes of hepatic clearance as hydroxylation and aromatization of the dihydropyrazolopyrimidine core. Significantly, in the course of in vitro metabolite identification studies, the formation of covalently bound glutathione (GSH) adducts were observed when these compounds were incubated with liver microsomes in the presence of GSH. The formation of a reactive metabolite was confirmed when the covalently bound protein adduct of radio-labeled compound <b>2</b> was subsequently identified.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> This was of concern as compounds which form reactive intermediates, (for example, those containing unsubstituted thiophenes)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and which irreversibly bind to protein in the liver can be hepatotoxic and have the additional liability of potential idiosyncratic toxicity when administered to a diverse patient population.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The site of reactive intermediate formation was determined using MS/MS fragmentation analysis, indicating oxidation of the fused pyrazole ring.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0013.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dihydropyrazolopyrimidines which form reactive intermediates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We therefore focused our optimization efforts on blocking the reactive intermediate formation by substitution at the C2 and C3 positions on the fused pyrazole ring.</div><div class="NLM_p">The first series of C2 substituted analogues containing a C6 phenylpiperazine amide were obtained from the general sequence utilizing the three-component, one-pot Biginelli reaction and commercially available amino-pyrazoles (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Synthesis of additional C2 and C3 substituted dihydropyrazolopyrimidines required initial preparation of noncommercially available amino-pyrazoles. Noncommercially available 3-substituted-1<i>H</i>-pyrazol-5-amines were synthesized from the corresponding amino pyrazoles using a multistep sequence, for example, compound <b>8</b>, Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18-21)</a> We had previously disclosed SAR in the piperazine amide series, including characterization of the C7 antipodes and determined that K<sub>v</sub>1.5 potency was retained in one antipode only.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Additional compounds in the piperazine amide series were synthesized and screened as racemates (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and the SAR utilized in pyrrolo amide series where the diastereomers were separated and characterized (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> and Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: yields (a) DMF, NaOAc, 65 Â°C, 14 h, yield range 27â60%.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, 120 Â°C, 4 h, 84% yield; (b) HCl, dioxane, isoamyl nitrate, â10 Â°C, 98% yield; (c) Cu(II)Cl<sub>2</sub> Cu(I)Cl, ether, MeOH, â10 Â°C, 86% yield; (d) AcOH, 90% HNO<sub>3</sub>, acetic anhydride, 0 Â°C, 32% yield; (e) anisole, 130 Â°C, 24 h, 100% yield; (f) Pd/C, hydrogen, 50 psi, 95% yield; (g) NaHCO<sub>3</sub>, DMF, 55 Â°C, 72 h, 24% yield.</p></p></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. C2 and C3-Substituted Phenylpiperazine Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0006.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">K<sub>v</sub>1.5 IC<sub>50</sub>, Î¼M<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">% inhibition of <i>h</i>ERG current at 10 Î¼M</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="center">42Â Â±Â 2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">0.124</td><td class="colsep0 rowsep0" align="center">60Â Â±Â 1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5b</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.149</td><td class="colsep0 rowsep0" align="center">29Â Â±Â 10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5c</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">0.419</td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">24%<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">F</td><td class="colsep0 rowsep0" align="left">0.209</td><td class="colsep0 rowsep0" align="center">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">C7 enantiomers separated and active antipode included.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Inhibition is measured in duplicate at 3 concentrations and the mean values used to calculate IC<sub>50</sub> values.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">% Inhibition of current in L-929 cells at 0.3 Î¼M, 2â4 point determinations.</p></div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. C6 Pyrrolo Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0007.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sub>1</sub></th><th class="colsep0 rowsep0" align="center">R<sub>2</sub></th><th class="colsep0 rowsep0" align="center">R<sub>3</sub></th><th class="colsep0 rowsep0" align="center">R<sub>5</sub></th><th class="colsep0 rowsep0" align="center">K<sub>v</sub>1.5 IC<sub>50</sub>, Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">% inhibition of <i>h</i>ERG current at 10 Î¼M</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">0.053</td><td class="colsep0 rowsep0" align="center">30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10a</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>OCH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-methylisoxazol-5-yl</td><td class="colsep0 rowsep0" align="left">0.070</td><td class="colsep0 rowsep0" align="center">14Â Â±Â 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10b</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">45%<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">0.100</td><td class="colsep0 rowsep0" align="center">10Â Â±Â 1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13b</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">4-fluorophenyl</td><td class="colsep0 rowsep0" align="left">37Â Â±Â 4.1%<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13c</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-methylisoxazol-5-yl</td><td class="colsep0 rowsep0" align="left">0.083</td><td class="colsep0 rowsep0" align="center">41Â Â±Â 0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13d</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-methylisoxazol-5-yl</td><td class="colsep0 rowsep0" align="left">0.165</td><td class="colsep0 rowsep0" align="center">13Â Â±Â 3.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13e</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-methylisoxazol-5-yl</td><td class="colsep0 rowsep0" align="left">0.101</td><td class="colsep0 rowsep0" align="center">47Â Â±Â 4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13f</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">3-methylisoxazol-5-yl</td><td class="colsep0 rowsep0" align="left">0.227</td><td class="colsep0 rowsep0" align="center">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">C7 diastereomers separated and active antipode included.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Inhibition is measured in duplicate at 3 concentrations and the mean values used to calculate IC<sub>50</sub> values.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Percent inhibition of current in L-929 cells at 0.3 Î¼M, 2â4 point determinations.</p></div></div></div><div class="NLM_p">A modified route was also subsequently used to allow installation of the C6 amide functionality at the final step (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF, NaHCO<sub>3</sub>, 65 Â°C, 24 h; (b) TMSOTf, DCM, RT; (c) EDCI, DCM, TEA, RT, 14 h.</p></p></figure><div class="NLM_p">Compounds containing C2 and C3 alkyl and halogen substituents were also prepared wherein the C6 phenylpiperazine amide substituent was replaced with the phenyl pyrrolo amide analogous to that found in compound <b>2</b> by the same general methods described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>, <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>. Additionally, C2 and C3 substituted compounds wherein the C6 substituent is a heterocyclo-pyrrolo group and the C7 substituent was replaced by a heterocycle were also prepared by essentially the same method utilizing a protection and deprotection sequence to improve the yield in the amide formation step (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). In the case wherein the C6 substituent was (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl) isoxazole amide, the noncommercial pyrrolo isoxazole was synthesized as shown in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The pyrrolo isoxazole was then coupled with the BOC protected dihydropyrazolopyrimidine carboxylic acids such as <b>11</b>, followed by deprotection of the BOC group, to yield the product as a mixture of diastereomers, which were then separated (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>).</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) heptane, catalytic piperidine, 75 Â°C, 120 h; (b) di-<i>tert</i>-butyl carbonate, THF, DMAP, RT; (c) LiOH, THF; (d) EDCI, DCM; (e) AcOH, microwave 150 Â°C, 2 min; (f) acetone oxime, nBuLi, THF, â15 Â°C to RT; (g) H<sub>2</sub>SO<sub>4</sub>, â15 Â°C to RT, 51% yield, 2 steps; (h) TfOH, DCM RT, 42% yield.</p></p></figure><div class="NLM_p last">Utilizing the chemistry described in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>â<a class="ref internalNav" href="#sch4" aria-label="4">4</a>, a series of C6 amide analogues <b>5a</b> to <b>12i</b> were synthesized. Selected mixtures of enantiomers were separated using chiral preparative chromatography (Chiralcel AD). Diastereomers were separated using normal phase silica gel chromatography. Enantiotopically pure compounds are indicated with an asterisk.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42171" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42171" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All compounds were assayed for block of I<sub>Kur</sub> current in patch clamped mammalian L-929 cells which were injected with human K<sub>v</sub>1.5 mRNA and stably expressed I<sub>Kur</sub> protein.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Inhibition and IC<sub>50</sub> data for compounds <b>1</b>â<b>13f</b> are shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. Compounds which were potent for K<sub>v</sub>1.5 were also evaluated for selectivity over the <i>h</i>ERG channel,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> (representative examples are shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). K<sub>v</sub>1.5 and <i>h</i>ERG channel activity for standard <b>1</b> is also included in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for comparison.</div><div class="NLM_p">We observed that direct analogues with a C2 (R<sub>1</sub>) methyl group on the dihydropyrazolopyrimidine were within 1â2-fold for K<sub>v</sub>1.5 potency (for example, <b>5a</b> compared to <b>1</b>, <b>13a</b> compared to <b>2</b>, and <b>13d</b> compared to <b>13c</b>). Substitution on the C2 (R<sub>1</sub>) position with chlorine resulted in a 4-fold loss of potency for K<sub>v</sub>1.5 (example <b>5d</b> compared to <b>1</b>) and, at the C3 (R<sub>2</sub>) position, a significant decrease in potency (example <b>5c</b> compared to <b>1</b>). Trifluoromethyl substitution at C2 (R<sub>1</sub>) reduced K<sub>v</sub>1.5 inhibition in the piperazine and phenylpyrrolidine amide series significantly as shown for examples <b>5c</b> and <b>13b</b> compared to the unsubstituted analogues <b>1</b> and <b>2</b>, respectively. However, we were surprised to observe that the C2-trifluoromethyl compound was equipotent with the 3-methylisoxazol-5-yl pyrrolidine amide analogues (compound <b>13e</b> compared to <b>13c</b>).</div><div class="NLM_p">Compound <b>10b</b> with a methyl substituent at C3 (R<sub>2</sub>) showed reduced K<sub>v</sub>1.5 inhibition and was not profiled further. Compounds <b>5a</b>, <b>13a</b>, and <b>13d</b> with the methyl substituent at C2, <b>and</b> compounds <b>13b</b> and <b>13e</b> with a trifluoromethyl substituent at C2 and C3 substituted analogues <b>5d</b> and <b>10b</b> were subsequently assayed to determine if reactive intermediates were formed.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">The potential for reactive intermediate formation was compared to the C2 and C3 unsubstituted analogues <b>2</b> and <b>13c</b>. The formation of reactive intermediates was quantified as fluorescent GSH adducts (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Dihydropyrazolopyrimidine C6 amides without substitution at positions 2 or 3 on the fused pyrazole showed significant incorporation of labeled GSH (<b>2</b> and <b>13c</b>). We were gratified to see that corresponding analogues with substituents at either C2 or C3 significantly reduced reactive intermediate formation, confirming that this is the principal site of oxidation on the dihydropyrazolopyrimidine template, (C2 substituted examples <b>5a</b>, <b>13a</b>, <b>13d</b>, and <b>13e</b> and C3 substituted analogues <b>5d</b> and <b>10b</b>). Potent K<sub>v</sub>1.5 inhibitors with acceptable selectivity versus <i>h</i>ERG and <1% of detected GSH adduct were advanced to in vitro liability screening and liver microsomal stability testing. C2 methyl analogues <b>5a</b> and <b>13a</b> and <b>13d</b> had poor liver microsome stability (human and rat) compared with C2 CF<sub>3</sub> analogue <b>13e</b>. Compound <b>13e</b> had the best combination of potency, selectivity, and microsomal stability and was advanced to PK profiling in rat and dog (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Compound <b>13e</b> had an acceptable PK profile in rat and dog with moderate clearance and good bioavailability and was further evaluated for efficacy in the rabbit pharmacodynamic model.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Percentage Parent Trapped As Fluorescent GSH Adduct</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">%fluorescent adducts as %initial parent</th><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char=".">%fluorescent adducts as %initial parent</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="left"><b>10b</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5a</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td><td class="colsep0 rowsep0" align="left"><b>13c</b></td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5d</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="left"><b>13d</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13a</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="left"><b>13e</b></td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr></tbody></table></div></div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. PK Summary for Compound <b>13e</b> in Rat and Dog</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (Î¼mol/kg)</td><td class="colsep0 rowsep0" align="left">12 iv; 26 po</td><td class="colsep0 rowsep0" align="left">5.6 iv, 5.2 po</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub>(h)</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i></td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">53</td></tr></tbody></table></div></div><div class="NLM_p">Like humans, rabbits express the I<sub>Kur</sub> current in atrium but not ventricle and compound <b>13e</b> demonstrated a dose dependent increase in atrial effective refractory period (AERP) without increasing ventricular effective refractory period (VERP) (Figure <a data-tab="pane-pcw-Figures" href="#fig1a" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> At a dose of 1 mg/kg, compound <b>13e</b> achieved a 20% increase in AERP at a plasma concentration of 1.7 Î¼M. This is noteworthy, as an increase of AERP by 10â20% in this model is considered sufficient to produce a clinically relevant effect.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Concomitant with evaluating compound <b>13e</b> in vivo, we sought to identify additional compounds which maintain the improved liability profile and further increase the potency in this series.</div><figure id="fig1a" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect on AERP and VERP in rabbit for compound <b>13e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig1a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Dose (mg/kg IV) with plasma concentration in Î¼M at each dose (<i>n</i> = 3)</p></p></figure><div class="NLM_p">After optimizing the substitution on the pyrazole ring to address the problem of reactive intermediate formation, we attempted to further optimize these compounds by modification of the substituent at the C7 position on the pyrazolodihydropyrimidine core (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). We reasoned that a bicyclic heterocycle may fill the same space as the dichlorophenyl group in the previous compounds. The 2-benzothiazole (<b>13g</b>) was 2â3-fold less potent than the corresponding 3,4-dichlorophenyl analogue, and 2-<i>N</i>-methyl indole (<b>13i</b>) showed similar potency to the dichlorophenyl analogue (<b>13e</b>). The <i>N</i>-methyl benzimidazole (<b>13h</b>) was significantly less potent than the isosteric <i>N</i>-methyl indole, possibly due to the greater basicity. Because of superior potency, the <i>N</i>-methylindole compound (<b>13i</b>) was chosen for further optimization of the 5-substituent. We had discovered that replacing the 5-methyl substituent in <b>13c</b> with the 5-methoxymethyl substituent was well tolerated when the 7-substituent was 3,4-dichlorophenyl as illustrated by compound <b>10a</b> compared to compound <b>13c</b>. Likewise, potency was maintained within 2-fold when the 5-methyl substituent was replaced with the 5-methoxymethyl substituent when the 7-substituent was <i>N</i>-methylindole as illustrated by compound <b>13j</b> compared to compound <b>13i</b>. In addition, we observed that compounds substituted with a methoxymethyl group at C5 had improved solubility in the vehicles used for PK dosing (PEG/EtOH/H<sub>2</sub>O) and subsequently the vehicle used for the slow infusion PD studies (DMF).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Examples of C7 Substituted Methylisoxazolopyrrolo Amides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0008.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0009.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn2"><div class="footnote" id="t5fn2"><sup>Table a</sup><p class="last">Inhibition is measured in duplicate at three concentrations and the mean values used to calculate IC<sub>50</sub> values.</p></div><div class="footnote" id="t5fn3"><sup>Table b</sup><p class="last">Percent Inhibition of current in L-929 cells at 0.3 Î¼M, 2â4 point determinations.</p></div><div class="footnote" id="t5fn1"><sup>Table c</sup><p class="last">*C7 diastereomers separated and active antipode included.</p></div></div><div></div></div><div class="NLM_p">Compound <b>13j</b> also showed good selectivity over other cardiac ion channels (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) and was evaluated for reactive intermediate formation in the same assay using fluorescently labeled glutathione. Like compound <b>13e</b>, compound <b>13j</b> showed less than 1% GSH adduct formation quantified by the detection of fluorescently labeled material.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Cardiac Ion Channel Inhibition for Compound <b>13j</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">channel/current</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub>(Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K<sub>v</sub>1.5</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>h</i>ERG</td><td class="colsep0 rowsep0" align="left">>10 (14% inhibition at 10 Î¼M)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I<sub>CaL</sub></td><td class="colsep0 rowsep0" align="left">>10 (37% inhibition at 10 Î¼M)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">I<sub>Na</sub></td><td class="colsep0 rowsep0" align="left">>10 (10% inhibition at 10 Î¼M)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">K<sub>v</sub>4.3</td><td class="colsep0 rowsep0" align="left">5.8</td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>13j</b> was evaluated for pharmacokinetic properties in rats and dogs (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) and showed acceptable half-life and bioavailability with moderate clearance. The pharmacodynamic effect of <b>13j</b> was tested in the rabbit PD model, which measured the effective refractory period (ERP) in both atrium and ventricle.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The compound was dosed at 0.3, 1.0, 3.0, and 10 mg/kg, and at a dose of 1 mg/kg, compound <b>13j</b> achieved a 20% increase in AERP at a plasma concentration of 0.7 Î¼M. There was no effect on VERP for either <b>13e</b> or <b>13j</b> reflecting the selectivity for K<sub>v</sub>1.5 over ventricular ion channels (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">3</a>). Because of the superior effect in the pharmacodynamic assay and the acceptable projected human dose derived from allometric scaling of the rat and dog PK properties, compound <b>13j</b> was chosen for additional characterization in preclinical toxicology studies.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. PK Summary for Compound <b>13j</b> in Rat, Dog, and Rabbit</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">rabbit</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dose (Î¼mol/kg)</td><td class="colsep0 rowsep0" align="left">12 iv; 25.5 po</td><td class="colsep0 rowsep0" align="left">5.6 iv, 5.2 po</td><td class="colsep0 rowsep0" align="left">5.6 iv</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub>(L/kg)</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">3.7</td><td class="colsep0 rowsep0" align="left">5.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub>(h)</td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">%<i>F</i></td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">ND</td></tr></tbody></table></div></div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0010.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect on AERP and VERP in rabbit for compound <b>13j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51828" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51828" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">In conclusion, we identified and blocked the site(s) of reactive intermediate formation in the described dihydropyrazolopyrimidine K<sub>v</sub>1.5 inhibitors. In general, although 1â2-fold less potent, the 2-methyl and 2-trifluoromethyl substituted analogues offered a profile worthy of follow up. Compound <b>13e</b> was identified with less than 1% GSH adduct formation with an improved PK profile and equivalent PD efficacy to lead compound <b>2</b>. Subsequent concomitant optimization at the C7 and C5 positions resulted in discovery of compound <b>13j</b>, a potent K<sub>v</sub>1.5 inhibitor which showed less than 1% GSH adduct formation and had an improved PK profile and increased PD efficacy compared to compounds <b>1</b> and <b>13e</b>. Compound <b>13j</b> was advanced to preclinical single dose toxicology studies in rats and dog, and there were no clinical observations related to liver toxicity observed.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reactions were carried out under a static atmosphere of argon or nitrogen and stirred magnetically unless otherwise stated. All reagents used were of commercial quality and were obtained from Aldrich Chemical Co., Sigma Chemical Co., Lancaster Chemical Co., Oakwood Chemical Co., and Matrix Chemical Co. <sup>1</sup>H (400 MHz) and <sup>13</sup>C (100 MHz) NMR spectra were recorded on a JEOL GSX400 spectrometer using tetramethylsilane as an internal standard unless otherwise stated. <sup>1</sup>H (500 MHz) and <sup>13</sup>C (125 MHz) NMR spectra were recorded on a JEOL JNM-ECP500 spectrometer. Chemical shifts are given in parts per million (ppm) downfield from internal reference tetramethylsilane in Î´ units, and coupling constants (<i>J</i> values) are given in hertz (Hz). Selected data are reported in the following manner: chemical shift, multiplicity, coupling constants. All reactions were carried out using commercially available anhydrous solvents from Aldrich Chemical Co. or EM Science Chemical Co. unless otherwise stated. All flash chromatographic separations were performed using E. Merck silica gel (particle size 0.040â0.063 mm). Reactions were monitored by TLC using 0.25 mm E. Merck silica gel plates (60 F<sub>254</sub>) and were visualized with UV light, with 5% phosphomolybdic acid in 95% EtOH, or by sequential treatment with 1N HCl/MeOH followed by ninhydrin staining. LC MS data were recorded on a Shimadzu LC-10AT equipped with a SIL-10A injector, a SPD-10AV detector, normally operating at 220 nm, and interfaced with a Micromass ZMD mass spectrometer. LC MS or HPLC retention times, unless otherwise noted, are reported using a Phenomenex Luna C-18 4.6 mm Ã 50 mm column eluted with a 4 min gradient from 0 to 100% B, where A = 10% MeOHâ90% H<sub>2</sub>Oâ0.1% TFA and B = 90% MeOHâ10% H<sub>2</sub>Oâ0.1% TFA. All solvents were removed by rotary evaporation under vacuum using a standard rotovap equipped with a dry ice condenser. All filtrations were performed with a vacuum unless otherwise stated. Purity of all intermediates and final compounds was determined to be >95% by HPLC (Phenomenex Luna C-18 4.6 mm Ã 50 mm column eluted with a 4 min gradient from 0 to 100% B, where A = 10% MeOHâ90% H<sub>2</sub>Oâ0.1% TFA and B = 90% MeOHâ10% H<sub>2</sub>Oâ0.1% TFA and detection at 220 nm (method A), Xbridge C18 3.5 Î¼m, 4.6 mm Ã 150 mm, 1.0 mL/min gradient 10â100% 95:5 AcCN in H<sub>2</sub>O (0.05% TFA) in 5:95 AcCN in H<sub>2</sub>O (0.05% TFA) (method B) and Xbridge Phenyl 3.5 Î¼m, 4.6 mm Ã 150 mm, 1.0 mL/min gradient 10â100% 95:5 AcCN in H<sub>2</sub>O (0.05% TFA) in 5:95 AcCN in H<sub>2</sub>O (0.05% TFA) (method C)) and/or elemental analyses.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> (7-(3,4-Dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-phenylpiperazin-1-yl)methanone (<b>5a</b>)</h3><div class="NLM_p last">1-(4-Phenylpiperazin-1-yl)butane-1,3-dione (<b>4a</b>) (0.40 g, 1.5 mmol) and 3,4-dichlorobenzaldehyde (0.32 g, 1.8 mmol) was dissolved in DMF (10 mL). NaOAc (0.37 g, 4.0 mmol) and 3-methyl-1<i>H</i>-pyrazol-5-amine (0.26 g, 1.9 mmol) were added and the solution heated to 55 Â°C for 24 h. The cooled solution was diluted with EtOAc and the organic portion washed with water and satd NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated. The residue was purified by silica gel chromatography elution with 1:1 hexane:acetone to yield <b>5a</b> as a pale-yellow solid (450 mg, 60% yield). <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.47 (d, <i>J</i> = 8.3 Hz, 1H), 7.22 (d, <i>J</i> = 2.0 Hz, 1H), 6.95 (m, 4H), 6.84 (m, 2H), 6.13 (s, 1H), 5.49 (s, 1H), 4.23 (br s, 2H), 3.31 (br s, 4H), 2.87 (br s, 2H), 2.12 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 169.66, 163.15, 160.50, 158.09, 155.36, 151.27, 149.22, 143.53, 141.83, 133.83, 133.01, 132.18, 129.87, 127.72, 120.37, 120.29, 116.55, 116.33, 100.60, 87.71, 61.27, 16.32, 13.19. LCMS: [M + 1] 500.1. HPLC: purity 94%, retention time 7.11 min, method B; purity 94%, retention time 7.18 min, method C.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> (7-(3,4-Dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-phenylpiperazin-1-yl)methanone (<b>5b</b>)</h3><div class="NLM_p last">(7-(3,4-Dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-phenylpiperazin-1-yl)methanone was prepared from <b>4a</b> and 3-methyl-1<i>H</i>-pyrazol-5-amine as described for example <b>5a</b> in 29% yield, <i>R</i><sub>f</sub> 0.29 5% MeOH in EtOAc. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.49 (d, <i>J</i> = 8.3 Hz, 1H), 7.21â7.29 (m, 3H), 7.00 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 6.92â6.82 (m, 3H), 6.16 (s, 1H), 5.51 (s, 1H), 4.29 (s, 2H), 3.38 (s, 4H), 2.97 (s, 2H),2.14 (s, 3H), 1.94 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 169.66, 152.54, 151.27, 143.50, 141.83, 133.87, 133.00, 132.16, 130.14, 129.84, 127.70, 122.03, 118.43, 100.62, 87.70, 61.69, 16.71, 13.66. HPLC: purity 96%, retention time 7.52 min, method B; purity 96%, retention time 7.58 min, method C. LCMS: [M + 1] 482.1, [M + 3] 484.1.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> (7-(3,4-Dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone (<b>5c</b>)</h3><div class="NLM_p last">(7-(3,4-Dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone was prepared from 1-(4-(4-fluorophenyl)piperazin-1-yl)butane-1,3-dione (<b>4b</b>) and 3,3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine as described for example <b>5a</b> in 46%yield, <i>R</i><sub>f</sub> 0.38 10% MeOH in DCM. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 8.00 (s, 1H), 7.52 (d, <i>J</i> = 8.3 Hz, 1H), 7.29 (dd, <i>J</i> = 12.4, 2.1 Hz, 1H), 7.09â6.93 (m, 3H), 6.89â6.79 (m, 2H), 6.28 (s, 1H), 5.95 (s, 1H), 4.24 (s, 1H), 3.87â3.68 (m, 1H), 3.58â3.16 (m, 4H), 1.96 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 169.04, 164.90, 160.53, 158.07, 149.22, 144.35, 143.88, 142.52, 142.20, 133.98, 133.46, 132.35, 130.05, 127.83, 120.37, 120.30, 116.56, 116.34, 101.09, 86.13, 62.52, 49.33, 49.55, 16.72. HPLC: purity 96%, retention time 10.32 min, method B; purity 95%, retention time 9.37 min, method C. LCMS: [M + 1] 554.1.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> (3-Chloro-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone (<b>5d</b>)</h3><div class="NLM_p last">7-(3,4-Dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone was prepared by the method described for <b>5a</b> from <b>4b</b> and pyrazol-5-amine in 27% yield. HPLC: purity 99%, retention time 8.59 min, method B; purity 99%, retention time 8.24 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.59 (s, 1H), 7.54 (d, <i>J</i> = 8.3 Hz, 1H), 7.32 (d,<i>J</i> = 2.1 Hz, 1H), 7.08â6.98 (m, 3H), 6.97â6.88 (m, 3H), 6.32 (s, 1H), 4.25 (brs, 1H), 3.44 (brs, 3H), 2.99 (brs, 1H), 2.65 (brs, 1H), 1.99 (s, 3H), 1.60 (brs, 1H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 169.08, 161.03, 160.30, 159.90, 158.65, 148.09,142.33, 142.01, 140.61, 134.07, 133.59, 132.41, 130.05, 127.84, 120.82, 120.74, 118.13, 116.81, 116.59, 115.34, 100.82, 61.98, 16.69. LCMS: [M + 1] 485.9, [M + 3] 487.7. 7-(3,4-Dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-(4-fluorophenyl)piperazin-1-yl)methanone (59 mg, 0.12 mmol) was dissolved in DCM (4 mL) and NCS (18 mg, 0.13 mmol) was added at 0 Â°C. After 30 min, the crude solution was applied directly to a prep TLC plate (25 cm Ã 25 cm, 1 mm thickness of silica) and eluted with 1:1 hexane:acetone. Compound <b>5d</b> was isolated as a white solid (38 mg, 61% yield). <sup>1</sup>H NMR (400 MHz, DMSO) Î´ 9.52 (s, 1H), 7.57 (d, <i>J</i> = 8.4 Hz, 1H), 7.44 (s, 1H), 7.26 (d, <i>J</i> = 1.8 Hz, 1H), 7.00â7.05 (m, 3H), 6.95 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (m, 2H), 6.08 (s, 1H), 4.00 (s, 2H), 3.20 (s, 4H), 2.90 (s, 2H), 1.90 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 181.55, 168.80, 157.93, 148.72, 142.56, 139.51, 137.46, 134.06, 133.09, 132.29, 130.10, 127.92, 120.39, 120.31, 116.56, 116.34, 101.43, 90.86, 62.53, 49.33, 49.12, 30.63, 16.59. HPLC: purity 94%, retention time 9.67 min, method B; purity 94%, retention time 8.89 min, method C. LCMS: [M + 1] 520.1.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-(1-(3,4-Dichlorophenyl)ethylidene)-1-(4-phenylpiperazin-1-yl)butane-1,3-dione (<b>6</b>)</h3><div class="NLM_p last">To a solution of <i>tert</i>-butyl 3-oxobutanoate (1.2 g, 7.7 mmol) in toluene (10 mL) was added 1-(4-fluorophenyl)piperazine (1.4 g, 7.7 mmol). The reaction mixture was heated to 120 Â°C for 4 h and then the cooled solution was extracted with HCl (1N aqueous solution, 3 Ã 20 mL). Satd NaHCO<sub>3</sub> was added to the combined aqueous portions until the pH was adjusted to pH 8. A white precipitate formed which was extracted into EtOAc. The combined EtOAc portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield intermediate 1-(4-(4-fluorophenyl)piperazin-1-yl)butane-1,3-dione (<b>4a</b>), which was used directly without further purification (1.7 g, 84% yield, 98% purity retention time 2.50 min). 1-(4-(4-Fluorophenyl)piperazin-1-yl)butane-1,3-dione (200 mg, 0.76 mmol) was dissolved in DMF (2 mL). To the reaction mixture was added 3,4-dichlorobenzaldehyde (0.13 g, 0.76 mmol), acetic acid (20 mg), piperidine (30 mg), and powdered 3A molecular sieves (100 mg). The resulting solution was heated to 55 Â°C for 14 h and then the cooled slurry was diluted with EtOAc (50 mL) and poured into LiCl (10% aqueous solution, 50 mL). The organic portion was separated and washed further with LiCl (10% aqueous solution), dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated. The residual oil was purified by column chromatography elution with 5:1 hexane:acetone to yield 2-(1-(3,4-dichlorophenyl)ethylidene)-1-(4-phenylpiperazin-1-yl)butane-1,3-dione (0.25 g, 79% yield, 98% purity retention time 4.16 min method A). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.53 (d, <i>J</i> = 2.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.1 Hz, 1H), 7.31 (dd, <i>J</i> = 2.0 and <i>J</i> = 8.4 Hz, 1H), 6.87 (m, 2H), 6.73 (m, 2H), 3.84 (t, <i>J</i> = 5.2 Hz, 2H), 3.30 (broad s, 1H), 3.20 (broad s, 1H), 3.05 (broad s, 1H), 2.95 (broad s, 1H), 2.90 (broad s, 1H), 2.50 (broad s, 1H), 2.37 (s, 3H). LCMS [M + 1] 421.07.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 3-Chloro-1<i>H</i>-pyrazol-5-amine (<b>7</b>)</h3><div class="NLM_p last">HCl (4.0 M in dioxane, 6.0 mL, 24 mmol) was added to a stirred solution of 1<i>H</i>-pyrazol-5-amine (1.5 g, 18 mmol) in MeOH (15 mL) at RT. After 3 h, the solvents were removed in vacuo and the residue redissolved in MeOH (10 mL). A further 3 mL of HCl (4.0 M in dioxane, 12 mmol) was added and the turbid solution stirred for 2 h and then concentrated, yielding a pale-yellow solid. The residue was redissolved in MeOH (15 mL) at 0 Â°C, and then isoamylnitrate was added dropwise (2.7 mL, 16 mmol). The resulting slurry was stirred at 0 Â°C for 90 min, diluted with ether (100 mL), and the solid collected by filtration and washed further with ether, yielding intermediate 5-diazo-1<i>H</i>-pyrazole (2.0 g, 98% yield). 5-Diazo-1<i>H</i>-pyrazole (1.0 g, 7.3 mmol) was suspended in concentrated HCl (10 mL), ether (10 mL), and MeOH (10 mL) at â10 Â°C, and then CuCl (0.038 g, 0.38 mmol) and CuCl<sub>2</sub> (0.50 g, 3.7 mmol) were added. The reaction mixture was stirred at 0 Â°C for 48 h and then poured into saturated ammonium hydroxide (37%, 30 mL) and then extracted with EtOAc. The combined organic portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated under reduced pressure to yield 5-chloro-1<i>H</i>-pyrazole (0.64 g, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.53 (broad s, 1H), 6.28 (broad s, 1H). 5-Chloro-1<i>H</i>-pyrazole (0.65 g, 6.3 mmol) was dissolved directly in acetic acid (0.91 mL) and then HNO<sub>3</sub> (90%, 0.91 mL) was added dropwise at 0 Â°C followed by acetic anhydride (2.3 mL). The reaction mixture allowed to warm to room temperature and stirred for 14 h and then poured cautiously into water (50 mL). The pH of the solution was adjusted to pH 7â8 by the addition of Na<sub>2</sub>CO<sub>3</sub> and the aqueous solution extracted with ether. The combined ether portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, concentrated, and the residue purified by column chromatography eluting with 4:1 hexane:EtOAc, yielding 3-chloro-1-nitro-1<i>H</i>-pyrazole as a white solid (0.30 g, 32% yield, <i>R</i><sub>f</sub> 0.65 in 4:1 hexane:EtOAc). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 8.31 (d, <i>J</i> = 4.4 Hz, 1H), 6.47 (d, <i>J</i> = 4.4 Hz, 1H). 3-Chloro-1-nitro-1<i>H</i>-pyrazole (0.30 g, 2.0 mmol) was dissolved in anisole (4 mL) and the solution heated at 130 Â°C for 48 h. The cooled reaction mixture was poured into 1:1 hexane:water (100 mL), the aqueous phase separated and the organic portion extracted with NaOH (10% aqueous solution, 4 Ã 10 mL). The combined aqueous extracts were acidified to pH 2 by the addition of concentrated HCl and extracted with EtOAc. The combined EtOAc extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield 3-chloro-5-nitro-1<i>H</i>-pyrazole as a white solid (0.30 g, 100% yield, <i>R</i><sub>f</sub> 0.2 in 4:1 hexane:EtOAc) <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 6.81 (s, 1H). HPLC: purity 97%, retention time 6.18 min, Xbridge C18 3.5 Î¼m, 4.6 mm Ã 150 mm, 1.0 mL/min gradient 10â100% 95:5 AcCN in H<sub>2</sub>O (0.05% TFA) in 5:95 AcCN in H<sub>2</sub>O (0.05% TFA); purity 97%, retention time 5.38 min, Xbridge Phenyl 3.5 Î¼m, 4.6 mm Ã 150 mm, 1.0 mL/min gradient 10â100% 95:5 AcCN in H<sub>2</sub>O (0.05% TFA) in 5:95 AcCN in H<sub>2</sub>O (0.05% TFA). A Parr thick walled reaction vessel was charged with chloro-5-nitro-1<i>H</i>-pyrazole (0.66 g, 4.5 mmol), Pd/C (33 mg, 5% by weight), and MeOH (40 mL). The reaction mixture was hydrogenated at 50 psi (3.6 atm) for 2 h 15 min. The reaction mixture was flushed with nitrogen, diluted with MeOH, and filtered through a pad of Celite. The solvents were removed to yield 3-chloro-1<i>H</i>-pyrazol-5-amine as brown needles (0.48 g, 95% yield, <i>R</i><sub>f</sub> 0.2 in 2:1 hexane:acetone). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 5.50 (s, 1H), 4.30 (broad s, 2H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 153.75, 142.43, 91.48. HPLC: purity 95%, retention time 3.20 min, method B; purity 95%, retention time 2.95 min, method C.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> (2-Chloro-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-phenylpiperazin-1-yl)methanone (<b>8</b>)</h3><div class="NLM_p last">A Teflon screw capped vial was charged with 2-(1-(3,4-dichlorophenyl)ethylidene)-1-(4-phenylpiperazin-1-yl)butane-1,3-dione (0.13 g, 0.31 mmol), 3-chloro-1<i>H</i>-pyrazol-5-amine (0.040 g, 0.34 mmol), NaHCO<sub>3</sub> (0.078 g, 0.93 mmol), and DMF (1.5 mL). The sealed reaction vessel was heated at 55 Â°C for 72 h and the cooled solution poured into LiCl (10% aqueous solution). The solution was extracted with EtOAc, and the combined organic portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated. The residue was purified by prep HPLC (YMC S5 ODS 30 mm Ã 100 mm, gradient 40â100% B where A = 10% MeOHâ90% H<sub>2</sub>Oâ0.1% TFA and B = 90%MeOHâ10% H<sub>2</sub>Oâ0.1% TFA and detection at 220 nm, retention time 10.1 min) to yield (2-chloro-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)(4-phenylpiperazin-1-yl)methanone (38 mg, 24% yield, 95% purity, retention time 4.27 min, method A). <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 7.27 (d <i>J</i> = 2.2 Hz, 1H), 7.01 (dd, <i>J</i> = 8.3 Hz and <i>J</i> = 2.2 Hz, 1H), 6.94â6.98 (m, 2H), 6.86 (m, 2H), 6.12 (s, 1H), 5.64 (s, 1H), 4.25 (s, 2H), 3.40 (s, 4H), 2.90 (s, 2H), 1.92 (s, 3H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 169.15, 159.53, 158.62, 142.19, 133.11, 132.31, 130.01, 127.84, 120.63, 118.62, 116.74, 116.52, 101.58, 87.11, 61.87, 49.68, 49.47, 49.26, 49.04, 48.83, 48.61, 48.40, 16.70. LCMS: [M + 1] 520.0, [M + 3] 522.0</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>10a</b>)</h3><div class="NLM_p last">Intermediate <i>tert</i>-butyl7-(3,4-dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (<b>9a</b>). To a solution of 1<i>H</i>-pyrazol-5-amine (5.4 g, 63 mmol) in DMF (50 mL) was added 3,4-dichlorobenzaldehyde (9.6 g, 53 mmol) and <i>tert</i>-butyl 4-methoxy-3-oxobutanoate (10 g, 53 mmol). NaHCO<sub>3</sub> (18 g, 252 mmol) was added, and the solution was heated at 65 Â°C for 24 h. The cooled reaction mixture was diluted with 10% LiCl solution in water (800 mL) and the precipitate collected, dissolved in DCM, and transferred to a separation funnel. The organic portion was further washed with 10% LiCl solution and the solvents evaporated. The residue was triturated with methanol to yield <b>9a</b> as a white powder (8.5 g, 39% yield, purity 91%, retention time 3.82 min). The material was separated into the corresponding enantiomers using a chiral cell AS column elution (5 cm Ã 50 cm, 20 Î¼m, Chiral Technologies) with 100% IPA (1% TEA) at 60 mL/min. Isomer 1 eluted at a retention time of 56 min, and isomer 2 eluted at a retention time of 98 min. Analytical data for isomer 1: HPLC purity 95%, retention time 11.16 min, method B; purity 95%, retention time 9.67 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.43 (d, <i>J</i> = 8.3 Hz, 1H), 7.41 (d, <i>J</i> = 2.1 Hz, 1H), 7.34 (d, <i>J</i> = 2.1 Hz, 1H), 7.11 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 6.23 (d, <i>J</i> = 9.9 Hz, 1H), 5.82 (d, <i>J</i> = 2.0 Hz, 1H), 4.76 (s, 2H), 3.50 (s, 3H), 1.35 (d, <i>J</i> = 10.0 Hz, 9H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 166.39, 147.84, 144.93, 141.56, 138.99, 133.04, 132.54, 131.58, 130.59, 127.92, 96.60, 90.21, 81.89, 70.70, 60.39, 59.49, 28.59, 27.97. LCMS [M + 1] 410.13. <i>tert</i>-Butyl 7-(3,4-dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (isomer 1) was treated with TMSOTf to yield 7-(3,4-dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid in 93% yield, purity 94%, retention time 3.02 min, method A. 7-(3,4-Dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions described for example <b>13a</b> to yield ((<i>R</i>)-7-(3,4-dichlorophenyl)-5-(methoxymethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a white solid (66% yield). HPLC: purity 100%, retention time 8.12 min, method B; purity 100%, retention time 7.75 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.47 (d, <i>J</i> = 7.8 Hz, 1H), 7.44 (d, <i>J</i> = 1.8 Hz, 1H), 7.21 (s, 1H), 6.99 (d, <i>J</i> = 8.1 Hz, 1H), 5.80 (brs, 1H), 5.69 (s, 1H), 5.70 (d, <i>J</i> = 2.2 Hz, 1H), 5.48 (s, 1H), 5.12 (m, 1H), 4.03 (m, 1H), 3.91 (pentet, <i>J</i> = 6.6 Hz, 2H), 3.64 (m, 1H), 3.34 (s, 3H), 3.20 (s, 1H), 2.24 (s, 3H), 1.95 (s, 2H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 173.43, 168.41, 161.41, 142.81, 141.56, 141.02, 133.68, 133.07, 131.92, 130.11, 127.95, 103.62, 103.18, 88.53, 69.87, 61.30, 59.04, 11.28. LCMS: [M + 1] 511.41. LCMS [M + 1] 487.9. HRMS calcd 488.126, obsd 488.126. The relative stereochemistry at the C7 postion was inferred from NMR analysis of the diagnostic proton shift for the methylene proton at C7.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone (<b>10b</b>)</h3><div class="NLM_p">Intermediate <i>tert</i>-butyl-7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (<b>9b</b>). To a solution of 4-methyl-1<i>H</i>-pyrazol-5-amine (0.36 g, 3.7 mol) in IPA (20 mL) was added 3,4-dichlorobenzaldehyde (0.43 g, 2.4 mol) and methyl 3-oxobutanoate (0.36 g, 2.4 mol). Heptane (4 mL) and piperidine (0.080 mg, 0.93 mmol) was added, and the solution was heated to 95 Â°C for 48 h. The cooled reaction mixture was concentrated in vacuo and the residue redissolved in THF and purified by silica gel chromatography gradient elution with 4:1 hexane:EtOAc to 2:1 hexane:EtOAc. <i>tert</i>-Butyl-7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was isolated as a pale-yellow powder (0.49 g, 51% yield, 99% purity, retention time 3.95 min, method A). <sup>1</sup>H NMR (400 MHz, THF-<i>d</i><sub>8</sub>) Î´ 8.68 (s, 1H), 7.39 (d, <i>J</i> = 1.6 Hz, 1H), 7.36 (d, <i>J</i> = 10.0 Hz, 1H), 7.12 (dd, <i>J</i> = 1.8 Hz and <i>J</i> = 8.4 Hz, 1H), 7.02 (s, 1H), 6.20 (s, 1H), 2.45 (s, 3H), 1.95 (s, 3H), 1.34 (s, 9H). HPLC: purity 95%, retention time 10.52 min, method B; purity 95%, retention time 9.11 min, method C. LCMS [M + 1] 394.46. Compound <b>11b</b> (0.20 g, 0.51 mmol) was dissolved in DCM (3 mL), and TMSOTf was added dropwise (0.20 g). The resulting slurry was stirred at room temperature for 1 h, the DCM was removed by pipet, and the residual solid dissolved in THF and treated with NaHCO<sub>3</sub> (0.5 g). The organic layer was purified by silica gel chromatography elution with EtOAc (1% AcOH), yielding 7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid as a white powder (0.15 g, 86% yield, 100% purity, retention time 3.89 min). HPLC: purity 99%, retention time 10.47 min, method B; purity 97%, retention time 9.65 min, method C. <sup>1</sup>H NMR (400 MHz, THF) Î´ 9.89 (s, 1H), 7.86 (s, 1H), 7.48 (d, <i>J</i> = 2.1 Hz, 1H), 7.42 (d, <i>J</i> = 8.8 Hz, 1H), 7.31 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 6.52 (s, 1H), 2.49 (s, 3H), 2.06 (s, 3H). <sup>13</sup>C NMR (101 MHz, THF) Î´ 164.22, 144.05, 139.23, 138.99, 134.74, 131.72, 131.35, 129.86, 128.38, 126.55, 100.96, 97.76, 57.87, 16.47, 5.08. LCMS [M + 1] 338.27, [M + 3] 340.41.</div><div class="NLM_p last">7-(3,4-Dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid and (<i>S</i>)-2-(4-fluorophenyl)pyrrolidine were coupled under the conditions described for the preparation of example <b>13a</b> to yield (7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone as a 1:1 mixture of diastereomers, which was separated by prep TLC plate (25 cm Ã 25 cm, 1 mm thickness) elution with 1:1 hexane:EtOAc (5% IPA). The <i>R</i><sub>f</sub> values for the diastereomers were 0.55 for ((<i>S</i>)-7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone and 0.45 for ((<i>R</i>)-7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone, which were isolated as white solids in yields of 4% and 5%, respectively. Analytical data for ((<i>R</i>)-7-(3,4-dichlorophenyl)-3,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone. HPLC: purity 95%, retention time 10.50 min, method B; purity 92%, retention time 10.19 min, method C. <sup>1</sup>H NMR (400 MHz, THF) Î´ 7.96 (s, 1H), 7.41 (d, <i>J</i> = 8.3 Hz, 1H), 7.29 (s, 1H), 7.06 (d, <i>J</i> = 8.3 Hz, 1H), 7.02â6.91 (m, 4H), 5.81 (d, <i>J</i> = 27.5 Hz, 1H), 4.91 (m, 1H), 3.74 (m, 3H), 3.44 (s, 2H), 2.18 (s, 3H), 1.92 (s, 3H), 1.58 (d, <i>J</i> = 13.2 Hz, 1H). LCMS [M + 1] 484.9.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl) ((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone (<b>13a</b>)</h3><div class="NLM_p">Intermediate (<i>R</i>)-4-<i>tert</i>-butyl-6-methyl-7-(3,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4,6(7<i>H</i>)-dicarboxylate was prepared as follows. To a solution of 3-methyl-1<i>H</i>-pyrazol-5-amine (3.0 g, 0.031 mol) in THF (15 mL) was added 3,4-dichlorobenzaldehyde (6.0 g, 0.034 mol) and methyl 3-oxobutanoate (4.0 g, 0.034 mol). Heptane (4 mL) and piperidine (0.080 mg,0.93 mmol) were added, and the solution was heated to 69 Â°C for 12 h. A white precipitate formed and the slurry diluted with hexane (25 mL), filtered, and the filter cake washed further with hexane and dried in vacuo to yield methyl-7-(3,4-dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate as a white powder (8.3 g, 76% yield, 95% purity, retention time 3.43 min, method A). LCMS: [M + 1] 352.0. To a slurry of methyl 7-(3,4-dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (4.0 g, 0.011 mol) in THF (37 mL) was added BOC anhydride (3.2 g, 0.014 mol) and DMAP (67 mg, 0.55 mol). The solution was stirred at RT for 2 h and then the solvents removed under reduced pressure. The residual oil was dissolved in DCM (100 mL), washed successively with 1 M HCl, satd NaHCO<sub>3</sub>, and satd NaCl, dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated, yielding racemic 4-<i>tert</i>-butyl-6-methyl-7-(3,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4,6(7<i>H</i>)-dicarboxylate (5.6 g, 100%, purity 95%, retention time 4.21 min). The racemate was separated into the corresponding enantiomers using a Chiral cell AD column (50 mm Ã 500 mm) elution with 1% anhydrous EtOH in heptane at a flow rate of 40 mL/min with detection at 254 nm. Enantiomer A eluted at a retention time of 70 min and entantiomer B at 582 min. Enantiomer B corresponded to (<i>R</i>)-4-<i>tert</i>-butyl-6-methyl-7-(3,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4,6(7<i>H</i>)-dicarboxylate and was isolated in 21% yield from the corresponding racemate in >98% ee purity, retention time 7.50 min, Chiral cell OD column (4.6 mm Ã 250 mm) elution with 2% IPA in heptane. HPLC: purity 98%, retention time 12.17 min, method B; purity 98%, retention time 10.30 min, method C. LCMS: [M + 1] 452.0, [M + 3] 454.0. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.23 (d, <i>J</i> = 2.1 Hz, 1H), 7.13 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.30 (s, 1H), 6.11 (s, 1H), 3.80 (s, 3H), 2.58 (s, 3H), 2.21 (s, 3H), 1.58 (s,9H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 166.47, 151.20, 150.95, 149.09, 141.20, 138.56, 133.85, 133.44, 132.15, 129.35, 127.57, 116.52, 97.42, 86.46, 59.36, 52.80, 28.28, 21.42, 13.92.</div><div class="NLM_p last">LiOH (10N aqueous solution, 5 mL) was added to a solution of (<i>R</i>)-4-<i>tert</i>-butyl-6-methyl-7-(3,4-dichlorophenyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4,6(7<i>H</i>)-dicarboxylate (0.53 g, 1.2 mmol) in THF (5 mL). The reaction mixture was stirred at RT for 15 h and then diluted with HCl (1N aqueous solution, 20 mL) and extracted with DCM. The combined organic portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield (<i>R</i>)-4-(<i>tert</i>-butoxycarbonyl)-7-(3,4-dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11a</b>) as an off-white powder (0.44 g, yield 87%, purity 92%, retention time 4.03 min, method A). LCMS [M + 1] 438.18. To a solution of <b>11a</b> (1.2 g, 2.7 mmol) in DCM (40 mL) was added EDCI (0.71 g, 3.7 mmol), HOBt (0.50 g, 3.7 mmol), and (<i>S</i>)-2-(4-fluorophenyl)pyrrolidine (0.61 g, 3.7 mmol). The reaction mixture was stirred at room temperature for 14 h and then diluted further with DCM (50 mL) and the solution washed successively with saturated NaHCO<sub>3</sub> and satd NaCl. The organic portion was dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield intermediate (<i>R</i>)-<i>tert</i>-butyl-7-(3,4-dichlorophenyl)-6-((<i>S</i>)-2-(4-fluorophenyl)pyrrolidine-1-carbonyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4(7<i>H</i>)-carboxylate as a tan solid (1.2 g, 75% yield, 95% purity at retention time 4.18 min). LCMS [M + 1] 585.16. To (<i>R</i>)-<i>tert</i>-butyl-7-(3,4-dichlorophenyl)-6-((<i>S</i>)-2-(4-fluorophenyl)pyrrolidine-1-carbonyl)-2,5-dimethylpyrazolo[1,5-<i>a</i>]pyrimidine-4(7<i>H</i>)-carboxylate (1.2 g, 2.0 mmol) was added 1:1 DCM:TFA solution (3 mL). The solution was stirred at room temperature for 3 h and then diluted with DCM, and the organic portion was washed with satd NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated. The residue was purified by silica gel chromatography elution with 1:1:0.1 hexane:EtOAc:IPA to yield compound <b>13a</b> as a white powder (0.22 g, 23% yield, 99% purity, retention time 6.83 min, method B); <i>R</i><sub>f</sub> 0.30 10% IPA in 1:1 hexane:EtOAc. <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 164.0, 162.5, 152.0, 145.0, 142.0, 141.0, 133.8, 133.7, 133.6, 132.0, 130.0, 128.3, 116.0, 102.8, 87.58, 62.0, 28.0, 17.0, 13.6. Due to rotomers, the proton spectra for this diastereomer had broad peaks as noted. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.15 (s, 1H), 7.32 (s, 1H), 6.95 (t, <i>J</i> = 8.0 Hz, 2H), 6.73 (s, 1H), 5.95 (s, 1H), 5.41 (s, 2H), 5.05 (s, 1H), 3.69 (s, 2H), 3.47 (m, 1H), 3.30 (s, 1H), 3.19 (s, 1H), 2.30 (s, 1H), 2.06 (s, 3H), 2.00â1.61 (m, 2H). HRMS [M + 1] obsd 485.1309, calcd 485.1311.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 4-(<i>tert</i>-Butoxycarbonyl)-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (<b>11b</b>)</h3><div class="NLM_p last">Methyl 7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was prepared as described for example <b>11a</b> from the condensation of 3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine, 3,4-dichlorobenzaldehyde, and methyl 3-oxobutanoate to yield intermediate methyl 7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate as an orange solid in 52% yield, 96% purity, retention time 2.90 min. <sup>1</sup>H NMR (400 MHz,) Î´ 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 7.31 (d, <i>J</i> = 2.1 Hz, 1H), 7.13 (dd, <i>J</i> = 8.3, 2.1 Hz, 1H), 6.63 (s, 1H), 6.38 (s, 1H), 5.87 (s, 1H), 3.61 (s, 3H), 2.52 (s, 3H). LCMS [M + 1] 405.95, [M + 3] 407.91. Methyl 7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was converted to 4-<i>tert</i>-butyl-6-methyl-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-4,6(7<i>H</i>)-dicarboxylate and subsequently hydrolyzed as described to 4-(<i>tert</i>-butoxycarbonyl)-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid using the procedure described in example <b>13a</b> in 94% yield. HPLC: purity 96%, retention time 11.85 min, method B; purity 93%, retention time 10.28 min, method C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) Î´ 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 7.30 (d, <i>J</i> = 2.1 Hz, 1H), 7.14 (dd, <i>J</i> = 8.3, 2.2 Hz, 1H), 6.51 (s, 1H), 6.47 (s, 1H), 2.66 (s, 3H), 1.59 (s, 9H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 167.30, 150.66, 148.79, 141.14, 140.15, 139.06, 136.23, 135.00, 134.15, 133.99, 133.81, 132.34, 129.36, 127.62, 117.59, 113.60, 86.98, 80.66, 60.48, 40.98, 28.17, 22.00, 21.21. LCMS: [M + 1] 491.8.</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone (<b>13b</b>)</h3><div class="NLM_p last">Compound <b>11b</b>and (<i>S</i>)-2-(4-fluorophenyl)pyrrolidine were coupled under the conditions described for the preparation of example <b>13a</b> to yield intermediate <i>tert</i>-butyl 7-(3,4-dichlorophenyl)-6-((<i>S</i>)-2-(4-fluorophenyl)pyrrolidine-1-carbonyl)-5-methyl-2-(trifluoromethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-4(7<i>H</i>)-carboxylate (0.53 g, 0.82 mmol) which was dissolved in 1:1 TFA:DCM (20 mL) and the reaction mixture stirred at room temperature for 3 h. The reaction mixture was concentrated and the residue azeotroped with toluene and then purified by silica gel chromatography elution with 1:3:7 IPA:EtOAc:hexane to yield ((<i>R</i>)-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone as the less polar diastereomer and ((<i>S</i>)-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(4-fluorophenyl)pyrrolidin-1-yl)methanone as the more polar diastereomer as white solids in yields of 29% and 17%, respectively. HPLC: purity 97%, retention time 3.86 min, method A. <sup>1</sup>H NMR (400 MHz,) Î´ 7.44 (s, 1H), 7.28 (d, <i>J</i> = 8.2 Hz, 1H), 7.09 (s, 1H), 7.02 (s, 2H), 6.88 (t, <i>J</i> = 8.5 Hz, 2H), 6.78 (d, <i>J</i> = 10.4 Hz, 2H), 6.23 (s, 1H), 5.56 (s, 1H), 4.86 (t, <i>J</i> = 7.7 Hz, 1H), 4.05â3.82 (m, 1H), 3.32 (s, 1H), 3.13 (s, 1H), 2.19 (m, 2H), 1.74 (s, 3H). <sup>19</sup>F NMR (376 MHz) Î´ â62.53, â114.61. <sup>13</sup>C NMR (101 MHz,) Î´ 167.43, 160.08, 138.57, 132.89, 130.77, 128.30, 127.50, 125.78, 115.45, 115.24, 103.29, 85.29, 77.32, 77.01, 76.69, 64.48, 60.62, 49.31, 34.85, 32.25, 25.32, 16.81, 0.99, â10.63. HRMS [M + 1] obsd 539.1028, calcd 539.1029.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13c</b>)</h3><div class="NLM_p last">(<i>R</i>)-4-(<i>tert</i>-Butoxycarbonyl)-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11c</b>) was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield ((<i>R</i>)-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone in 26% yield. HPLC: purity 95%, retention time 7.88 min, method B; purity 96%, retention time 7.59 min, method C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.39 (d, <i>J</i> = 8.3 Hz, 1H), 7.35 (d, <i>J</i> = 1.9 Hz, 1H), 7.25 (d, <i>J</i> = 4.4 Hz, 1H), 7.24 (d, <i>J</i> = 1.9 Hz, 1H), 7.01 (dd, <i>J</i> = 8.3, 1.8 Hz, 1H), 6.50 (s, 1H), 6.07 (s, 1H), 5.53 (d, <i>J</i> = 1.9 Hz, 1H), 5.52 (s, 1H), 3.52 (s, 1H), 3.19 (s, 1H), 2.24 (s, 3H), 2.02â1.84 (m, 5H), 2.04 (s, 2H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 173.58, 161.88, 151.20, 143.56, 141.76, 133.45, 132.88, 131.93, 130.13, 127.99, 103.10, 102.44, 87.74, 61.17, 16.88, 13.64, 11.32. LCMS: [M + 1] 458.1, [M + 3] 460.1</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13d</b>)</h3><div class="NLM_p last">Compound <b>11a</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield ((<i>R</i>)-7-(3,4-dichlorophenyl)-2,5-dimethyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone in 64% yield. HPLC: purity 94%, retention time 7.22 min, method B; purity 96%, retention time 7.32 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.50 (d, <i>J</i> = 8.3 Hz, 1H), 7.22 (d, <i>J</i> = 1.7 Hz, 1H), 7.02 (dd, <i>J</i> = 8.3, 1.9 Hz, 1H), 5.92 (s, 1H), 5.72 (s, 1H), 5.48 (s, 1H), 5.11 (s, 1H), 3.62 (dt, <i>J</i> = 10.8, 7.1 Hz, 1H), 3.21 (s, 1H), 2.26 (s, 3H), 2.12 (s, 3H), 1.98 (m, 4H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 173.58, 161.41, 151.20, 143.56, 141.76, 133.45, 132.88, 131.93, 130.13, 127.99, 103.10, 102.44, 87.74, 61.17, 16.88, 13.64, 11.32. LCMS: [M + 1] 472.1, [M + 3] 474.1</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> ((<i>R</i>)-7-(3,4-Dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13e</b>)</h3><div class="NLM_p last">Compound <b>11b</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield ((<i>R</i>)-7-(3,4-dichlorophenyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone in 36% yield. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.52 (d, <i>J</i> = 8.3 Hz, 1H), 7.30 (s, 1H), 7.08 (d, <i>J</i> = 8.2 Hz, 1H), 6.14 (s, 1H), 5.92 (s, 1H), 5.69 (s, 1H), 5.13 (s, 1H), 3.65 (dt, <i>J</i> = 10.8, 7.2 Hz, 1H), 2.17 (s, 3H), 2.00 (s, 3H), 1.31 (m, 4H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 173.55, 161.44, 142.27, 141.58, 133.58, 133.34, 132.06, 130.39, 128.80, 128.17, 126.58, 103.04, 102.77, 86.17, 61.90, 49.69, 49.47, 49.26, 49.05, 48.83, 48.62, 48.41, 16.88, 11.29. HPLC: purity 98%, retention time 9.83 min, method B; purity 98%, retention time 8.92 min, method C. LCMS: [M + 1] 526.2</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 4-(<i>tert</i>-Butoxycarbonyl)-2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (<b>11f</b>)</h3><div class="NLM_p">Intermediate methyl 2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate. To a solution of 3-cyclopropyl-1<i>H</i>-pyrazol-5-amine (1.0 g, 8.1 mol)in THF (50 mL) was added 3,4-dichlorobenzaldehyde (1.4 g, 8.1 mol) and methyl 3-oxobutanoate (0.94 g, 8.1 mol). Heptane (10 mL) and piperidine (0.020 mg, 0.24 mmol) were added, and the solution was heated to 75 Â°C for 18 h. The cooled reaction mixture was concentrated in vacuo and the residue redissolved in THF and purified by silica gel chromatography gradient elution with 2:1 hexane:EtOAc. Methyl 2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was isolated as a tan solid (1.7 g, 56% yield, <i>R</i><sub>f</sub> 0.2 in 2:1 hexane:EtOAc). HPLC: purity 99%, retention time 9.42 min, method B; purity 100%, retention time 8.57 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.41 (d, <i>J</i> = 8.4, 1H), 7.31 (dd, <i>J</i> = 8.9, 2.2 Hz, 1H), 7.09 (dd, <i>J</i> = 8.4, 2.2 Hz, 1H), 6.18 (s, 1H), 5.38 (s, 1H), 3.66 (s, 3H), 2.44 (s, 3H), 1.91â1.48 (m, 1H), 1.02â0.75 (m, 2H), 0.71â0.46 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 168.19, 158.29, 148.13, 145.17, 139.83, 133.08, 132.39, 131.51, 130.09, 127.74, 115.68, 97.20, 85.25, 59.82, 51.45, 19.43, 10.18, 8.50, 8.30. LCMS [M + 1] 378.19</div><div class="NLM_p last">Methyl 2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was treated with BOC anhydride and the methyl ester hydrolyzed as described for example <b>11a</b> to yield 4-(<i>tert</i>-butoxycarbonyl)-2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11f</b>) as an orange foam (0.71 g, 82% yield for 2 steps). HPLC: purity 99%, retention time 11.18 min, method B; purity 99%, retention time 9.80 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.48 (d, <i>J</i> = 8.4 Hz, 1H), 7.22 (t, <i>J</i> = 2.1 Hz, 1H), 7.10 (dd, <i>J</i> = 8.0, 2.0 Hz 1H), 6.32 (s, 1H), 6.00 (s, 1H), 2.70 (s, 3H), 1.97â1.76 (m, 1H), 1.58 (m, 9H), 1.02â0.83 (m, 2H), 0.78â0.60 (m, 2H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 157.76, 151.09, 141.72, 138.79, 132.13, 129.20, 127.36, 117.96, 107.21, 94.44, 89.14, 86.22, 75.48, 59.75, 28.22, 21.27, 13.35, 10.24, 8.51. LCMS: [M + 1] 478.15.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> ((<i>R</i>)-2-Cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13f</b>)</h3><div class="NLM_p last">Compound <b>11f</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield a 1:1 diasteromeric mixture of (2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone in 51% yield. The diastereomers were separated using prep TLC (25 cm Ã 25 cm Ã 1 mm thickness) elution with 1:1 hexane:EtOAc (10% IPA). The <i>R</i><sub>f</sub> values for the diastereomers were 0.60 for ((<i>R</i>)-2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone and 0.35 for ((<i>S</i>)-2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone, which were isolated as white solids in yields of 31% and 22%, respectively. Analytical data for ((<i>R</i>)-2-cyclopropyl-7-(3,4-dichlorophenyl)-5-methyl-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. HPLC: purity 99%, retention time 8.96 min, method B; purity 98%, retention time 8.90 min, method C. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.47 (d, <i>J</i> = 8.3 Hz, 1H), 7.17 (d, <i>J</i> = 1.7 Hz, 1H), 6.96(dt, <i>J</i> = 6.7, 3.4 Hz, 1H), 6.07â5.56 (m, 1H), 5.26 (s, 1H), 5.02 (s, 1H), 3.96â3.84 (m, 1H), 3.59 (dd, <i>J</i> = 10.2, 6.9 Hz, 1H), 2.23 (s, 4H), 1.91 (s, 7H), 1.80â1.66 (m, 1H), 0.92â0.86 (m, 1H), 0.86â0.80 (m, 2H), 0.66â0.53 (m, 2H). <sup>13</sup>C NMR (101 MHz, THF) Î´ 170.49, 168.43, 164.23, 158.03, 151.52, 146.01, 140.87, 139.28, 129.71, 127.87, 126.84, 124.75, 100.27, 99.18, 95.09, 80.49, 65.03, 64.81, 64.59, 64.37, 64.15, 57.39, 51.24, 28.71, 27.10, 22.90, 22.70, 22.50, 22.31, 22.11, 14.07, 8.44, 7.37, 5.27. LCMS: [M + 1] 498.17.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 7-(Benzo[<i>d</i>]thiazol-2-yl)-4-(<i>tert</i>-butoxycarbonyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (<b>11g</b>)</h3><div class="NLM_p">Intermediate methyl 7-(benzo[d]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate. Methyl 7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was prepared from the condensation of benzo[<i>d</i>]thiazole-2-carbaldehyde, 3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine, and methyl 3-oxobutanoate as described in example <b>11a</b>. The solvents from the reaction mixture were removed in vacuo and the residue dissolved in MeOH. The resulting white precipitate was collected and dried to yield methyl 7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate in 61% yield. HPLC: purity 97%; retention time 2.31 min; method A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 9.91 (s, 1H), 7.96â7.92 (m, 1H), 7.88â7.84 (m, 1H), 7.51â7.42 (m, 2H), 6.91 (s, 1H), 5.62 (s, 1H), 3.74 (s, 3H), 2.22 (s, 3H). LCMS [M + 1] 395.22.</div><div class="NLM_p last">Methyl 7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was treated with BOC anhydride and the methyl ester hydrolyzed as described for example <b>11a</b> to yield 7-(benzo[<i>d</i>]thiazol-2-yl)-4-(<i>tert</i>-butoxycarbonyl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11g</b>) in 95% yield. HPLC: purity 100%, retention time 10.92 min, method B; purity 100%, retention time 9.69 min, method C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.99 (d, <i>J</i> = 7.9 Hz, 1H), 7.80 (d, <i>J</i> = 7.9 Hz, 1H), 7.48â7.42 (m, 1H), 7.40â7.34 (m, 1H), 6.97 (s, 1H), 6.59 (s, 1H), 2.67 (s, 3H), 1.59 (s, 9H). LCMS [M + 1] 481.32. <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 168.14, 167.07, 153.94, 150.56, 149.98, 139.79, 136.57, 127.70, 127.08, 124.30, 123.10, 116.02, 96.51, 86.80, 59.48, 44.51, 28.21, 21.19, â1.95. LCMS [M + 1] 480.9.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> ((<i>S</i>)-7-(Benzo[d]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13g</b>)</h3><div class="NLM_p last">Compound <b>11g</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield a 1:1 diasteromeric mixture of 7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. The diastereomers were separated using silica gel chromatography gradient elution with 10% EtOAc in hexane to 100% EtOAc over 20 min. The retention times for the diastereomers were 14 min for ((<i>R</i>)-7-(benzo[d]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone and 17.5 min for ((<i>S</i>)-7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone, which were isolated as white solids in yields of 53% and 50%, respectively. Analytical data for ((<i>S</i>)-7-(benzo[<i>d</i>]thiazol-2-yl)-5-methyl-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. HPLC: purity 98%, retention time 10.05 min, method B; purity 99%, retention time 9.35 min, method C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.93 (d, <i>J</i> = 7.9 Hz, 1H), 7.82 (d, <i>J</i> = 8.3 Hz, 1H), 7.47â7.34 (m, 2H), 6.88 (s, 1H), 6.46 (s, 1H), 6.03 (s, 1H), 5.83 (s, 1H), 5.31 (t, <i>J</i> = 7.7 Hz, 1H), 3.77â3.70 (m, 1H), 3.52â3.40 (m, 1H), 2.21 (m, 3H), 2.08 (m, 3H), 1.93 (m, 2H). <sup>13</sup>C NMR (126 MHz, MeOD) Î´ 168.74, 150.61, 140.60, 133.00, 124.52, 123.77, 121.37, 120.20, 100.08, 97.67, 83.24, 57.62, 51.95, 21.89, 13.41, 8.23, â3.81. LCMS [M + 1] 515.31.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 4-(<i>tert</i>-Butoxycarbonyl)-5-methyl-7-(1-methyl-1<i>H</i>-benzo[d]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (<b>11h</b>)</h3><div class="NLM_p">Intermediate methyl 5-methyl-7-(1-methyl-1<i>H</i>-benzo[d]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate. Methyl 5-methyl-7-(1-methyl-1<i>H</i>-benzo[d]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was prepared from the condensation of 1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazole-2-carbaldehyde, 3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine, and methyl 3-oxobutanoate as described in example <b>11a</b>. The solvents from the reaction mixture were removed in vacuo and the residue dissolved in MeOH. The resulting white precipitate was collected and dried to yield methyl 5-methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate in 56% yield. HPLC: purity 87%, retention time 2.99 min, method A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 12.61 (brs, 1H), 7.58 (d, <i>J</i> = 8.35 Hz, 1H), 7.50 (d, <i>J</i> = 8.35 Hz, 1H), 7.38 (t, <i>J</i> = 7.69 Hz, 1H), 7.29 (t, <i>J</i> = 7.69 Hz, 1H), 6.78 (s, 1H), 4.21 (s, 3H), 3.66 (s, 3H), 1.56 (s, 3H). LCMS: [M + 1] 392.29.</div><div class="NLM_p last">Methyl 5-methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was treated with BOC anhydride and the methyl ester hydrolyzed as described for example <b>11a</b> to yield <b>11h</b> in 50% yield. HPLC: purity 94%, retention time 3.13 min, method A. HPLC: purity 96%, retention time 8.91 min, method B; purity 100%, retention time 8.72 min, method C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.60 (d, <i>J</i> = 8.35 Hz, 1H), 7.30â7.26 (m, 2H), 7.21â7.16 (m, 1H), 6.80 (s, 1H), 6.47 (s, 1H), 3.99 (s, 3H), 2.71 (s, 3H), 1.57 (s, 9H). LCMS [M + 1] 478.36. <sup>13</sup>C NMR (101 MHz, THF) Î´ 165.45, 150.34, 149.16, 148.68, 142.77, 138.37, 135.99, 122.38, 121.57, 119.66, 114.15, 109.73, 95.21, 84.17, 52.53, 29.42, 27.22, 20.20. LCMS: [M + 1] 477.9.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> ((<i>S</i>)-5-Methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13h</b>)</h3><div class="NLM_p last">Compound <b>11h</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>13a</b> to yield a 1:1 diasteromeric mixture of (5-methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. The diastereomers were separated using silica gel chromatography gradient elution with 25% EtOAc in hexane to 100% EtOAc over 20 min. The retention times for the diastereomers were 15 min for ((<i>R</i>)-5-methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone and 21.5 min for ((<i>S</i>)-5-methyl-7-(1-methyl-1<i>H</i>-benzo[<i>d</i>]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone, which were isolated as white solids in yields of 30% and 28%, respectively. Analytical data for ((<i>S</i>)-5-methyl-7-(1-methyl-1<i>H</i>-benzo[d]imidazol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone is as follows. HPLC: purity 96%, retention time 6.87 min, method B; purity 96%, retention time 7.74 min, method C. <sup>1</sup>H NMR (400 MHz,) Î´ 7.63 (d, <i>J</i> = 7.9 Hz, 1H), 7.44 (d, <i>J</i> = 8.0 Hz, 1H), 7.33 (t, <i>J</i> = 7.2 Hz, 1H), 7.27 (d, <i>J</i> = 7.1 Hz, 1H), 6.44â6.16 (m, 1H), 5.47 (s, 1H), 5.23 (s, 1H), 3.83 (s, 1H), 3.69 (s, 1H), 2.25 (s, 1H), 2.04 (s, 3H), 2.11â1.94 (m, 6H), 1.58 (s, 3H). <sup>13</sup>C NMR (101 MHz, THF) Î´ 120.60, 119.89, 117.59, 107.95, 51.84, 27.67, 14.27, 7.72. LCMS: [M + 1] 512.36</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-(<i>tert</i>-Butoxycarbonyl)-5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11i</b>)</h3><div class="NLM_p">Intermediate methyl 5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate. Methyl 5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was prepared from the condensation of 1-methyl-1<i>H</i>-indole-2-carbaldehyde,3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine, and methyl 3-oxobutanoate as described in example <b>11a</b>. The solvents from the reaction mixture were removed in vacuo and the residue dissolved in MeOH. The resulting white precipitate was collected and dried to yield methyl 5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate in 55% yield. HPLC: purity 99%, retention time 1.94 min, method A. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.52 (d, <i>J</i> = 8.35 Hz, 1H), 7.24â7.15 (m, 2H), 7.07â7.02 (m, 2H), 6.80 (s, 1H), 6.73 (s, 1H), 5.76 (s, 1H), 3.67 (s, 3H), 3.62 (s, 3H), 2.47 (s, 3H). LCMS: [M + 1] 391.26.</div><div class="NLM_p last">Methyl 5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate was treated with BOc anhydride and the methyl ester hydrolyzed as described for example <b>11a</b> to yield 4-(<i>tert</i>-butoxycarbonyl)-5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid (<b>11i</b>) in 73% yield. HPLC: purity 95%, retention time 3.82 min, method A. HPLC: purity 100%, retention time 10.95 min, method B; purity 100%, retention time 9.76 min, method C. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.47 (d, <i>J</i> = 7.91 Hz, 1H), 7.33â7.28 (m, 1H), 7.21 (t, <i>J</i> = 7.47 Hz, 1H), 7.04 (t, <i>J</i> = 7.25 Hz, 1H), 6.74 (s, 1H), 6.41 (s, 1H), 6.37 (s, 1H), 4.05 (s, 3H), 2.72 (s, 3H), 1.56 (s, 9H). <sup>13</sup>C NMR (101 MHz, THF) Î´ 163.48, 147.38, 144.32, 135.91, 135.09, 125.52, 124.53, 119.84, 117.66, 117.46, 115.33, 109.52, 107.21, 92.72, 82.43, 52.11, 29.85, 25.21,18.02. LCMS: [M + 1] 477.36.</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> ((<i>S</i>)-5-Methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13i</b>)</h3><div class="NLM_p last">Compound <b>11i</b> was coupled to (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>) using the conditions and subsequent deprotection described for example <b>11</b> to yield a 1:1 diasteromeric mixture of 5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. The diastereomers were separated using silica gel chromatography gradient elution with 10% EtOAc in hexane to 50% EtOAc over 20 min. The retention times for the diastereomers were 13 min for ((<i>R</i>)-5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone and 16 min for ((<i>S</i>)-5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone, which were isolated as yellow solids in yields of 36% and 32%, respectively. Analytical data for ((<i>S</i>)-5-methyl-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone. HPLC: purity 95%, retention time 9.39 min, method B; purity 94%, retention time 8.67 min, method C. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) Î´ 7.65 (m, 1H), 7.53 (t, <i>J</i> = 10.7 Hz, 1H), 7.36 (d, <i>J</i> = 8.3 Hz, 1H), 7.20 (ddd, <i>J</i> = 24.1, 12.6, 9.1 Hz, 1H), 7.07 (dt, <i>J</i> = 16.1, 4.5 Hz, 1H), 6.44 (s, 1H), 5.92 (s, 1H), 5.01 (s, 1H), 3.95 (m, 1H), 3.60 (s, 2H), 3.54 (s, 3H), 3.28 (s, 1H), 2.03 (s, 3H), 1.98 (s, 2H). <sup>13</sup>C NMR (101 MHz, CD<sub>3</sub>CN) Î´ 185.44, 182.95, 173.53, 166.86, 162.84, 141.31, 140.33, 138.39, 132.08, 127.62, 123.07, 121.60, 120.75, 118.30, 110.61, 103.61, 102.18, 98.30, 86.00, 54.67, 47.31, 38.51, 30.31, 17.15, 11.41. LCMS: [M + 1] 511.41.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 4-(<i>tert</i>-Butoxycarbonyl)-5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic Acid (<b>11j</b>)</h3><div class="NLM_p last">To a solution of 3-(trifluoromethyl)-1<i>H</i>-pyrazol-5-amine (2.4 g, 16 mmol) in THF (8 mL) was added 1-methyl-1<i>H</i>-indole-2-carbaldehyde (2.5 g, 16 mmol) and methyl 3-oxobutanoate (2.0 g mL, 16 mmol). Heptane (2 mL) and piperidine (78 uL, 0.79 mmol) was added, and the solution was heated to 75 Â°C for 120 h. The cooled reaction mixture was purified directly using silica gel chromatography gradient elution with 20â80% EtOAc in hexane over 40 min to yield methyl 5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate as a white powder (2.3 g, 35% yield, 95% purity, retention time 3.43 min, method A). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) Î´ 7.99 (s, 1H), 7.49 (d, <i>J</i> = 7.9 Hz, 1H), 7.35 (d, <i>J</i> = 8.3 Hz, 1H), 7.06 (s, 1H), 6.69 (s, 1H), 6.30 (s, 1H), 5.90 (s, 1H), 4.90 (s, 2H), 4.06 (s, 3H), 3.59 (s, 3H), 3.60 (s, 3H). To a slurry of methyl 5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylate (2.3 g, 5.5 mmol) in THF (10 mL) was added BOC anhydride (1.4 g, 6.6 mmol) and DMAP (33 mg, 0.27 mmol). The solution was stirred at room temperature for 2 h and then water (10 mL) and LiOH (0.23 g, 5.5 mmol) added. After 14 h, additional LiOH was added (0.46 g, 11 mmol) and the solution stirred for an additional 14 h. The reaction mixture was neutralized by the addition of 1 M HCl and the aqueous portion extracted with EtOAc. The combined organic portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield 4-(<i>tert</i>-butoxycarbonyl)-5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidine-6-carboxylic acid as a brown solid (2.5 g, 100% yield). <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.46 (d, <i>J</i> = 7.9 Hz, 1H), 7.38 (s, 1H), 7.23â7.14 (m, 1H), 7.06â6.95 (m, 1H), 6.86 (s, 1H), 6.54 (s, 1H), 6.37 (s, 1H), 5.24 (d, <i>J</i> = 15.1 Hz, 1H), 4.92 (d, <i>J</i> = 15.1 Hz, 1H), 4.05 (s, 3H), 3.30 (s, 3H), 1.61 (s, 9H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 167.27, 150.90, 148.29, 139.77, 138.78, 136.29, 128.24, 123.64, 121.71, 120.96, 117.60, 110.77, 101.89, 95.29, 86.40, 69.88, 58.83, 54.24, 30.66, 28.12. HPLC: purity 90%, retention time 11.38 min, method B; purity 91%, retention time 9.96 min, method C. LCMS: [M + 1] 507.0.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>)-3-Methyl-5-(pyrrolidin-2-yl)isoxazole (<b>12</b>)</h3><div class="NLM_p last">Propan-2-one oxime (0.42 g, 5.7 mmol) was dissolved in THF (10 mL), and nBuLi (4.6 mL, 2.5 M solution in hexane, 11 mmol) was added dropwise. The reaction mixture was stirred for 30 min, cooled to 0 Â°C, and (<i>S</i>)-1-benzyl 2-methyl pyrrolidine-1,2-dicarboxylate (1.0 g, 3.8 mmol) was added and the solution stirred for 1.5 h. Concentrated H<sub>2</sub>SO<sub>4</sub> was added dropwise (3.5 mL), and the reaction mixture was stirred for an additional 1.5 h and poured cautiously into a 1:1 mixture of ice and NH<sub>4</sub>OH. The aqueous portion was extracted with ether and the combined organic portions dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield intermediate (<i>S</i>)-benzyl 2-(3-methylisoxazol-5-yl)pyrrolidine-1-carboxylate, which was purified by silica gel chromatography elution with hexane:acetone (3:1) as a yellow oil (0.55 g, 51% yield, 93% purity retention time 1.99 min). (<i>S</i>)-Benzyl 2-(3-methylisoxazol-5-yl)pyrrolidine-1-carboxylate (0.39 g, 1.4 mmol) was dissolved in DCM (8 mL), and triflic acid (1.0 g, 6.8 mmol) was added dropwise and the solution stirred for 15 min. Water was added, followed by NaOH (1M), until the pH was adjusted to pH 8. The organic layer was separated and the aqueous portion extracted further with DCM. The combined organic portions were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated and the residue purified by silica gel chromatography elution with DCM:MeOH (10:1) yielding (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole as a colorless oil (0.87 g, 42% yield). To prevent decomposition, (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole was stored as the NBS monosalt. <sup>1</sup>H NMR (400 MHz, MeOD) Î´ 7.72 (d, <i>J</i> = 6.4 Hz, 1H), 7.26 (d, <i>J</i> = 7.9 Hz, 1H), 6.52 (s, 1H), 4.91 (t, <i>J</i> = 7.7 Hz, 1H), 3.47 (dd, <i>J</i> = 10.3, 4.2 Hz, 1H), 2.60â2.44 (m, 1H), 2.39 (s, 3H), 2.31 (s, 3H), 2.32â2.26 (m, 2H), 2.29â2.09 (m, 1H). <sup>13</sup>C NMR (101 MHz, MeOD) Î´ 167.03, 162.03, 143.53, 141.84, 129.92, 126.99, 106.35, 55.55, 47.02, 30.12, 24.66, 21.37, 11.23. HPLC: purity 99%, retention time 4.17 min, method B; purity 95%, retention time 2.12 min, method C. LCMS: [M + 1] 152.9.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> ((<i>S</i>)-5-(Methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13j</b>)</h3><div class="NLM_p last">To compound <b>11j</b> (0.44 g, 0.87 mmol) in DCM (5 mL) was added EDCI (0.18 g, 0.95 mmol) and (<i>S</i>)-3-methyl-5-(pyrrolidin-2-yl)isoxazole (0.13 g, 8.7 mmol). The reaction mixture was stirred at room temperature for 2 h and then purified directly by silica gel chromatography gradient elution with 0â100% EtOAc in hexane over 18 min to yield a diastereomeric mixture of <i>tert</i>-butyl 5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-6-((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidine-1-carbonyl)-2-(trifluoromethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-4(7<i>H</i>)-carboxylate as a yellow powder (0.38 g, 69% yield, 95% purity at retention time 2.41 min, method A). <sup>1</sup>H NMR (400 MHz,) Î´ 7.51 (t, <i>J</i> = 10.2 Hz, 1H), 7.32 (d, <i>J</i> = 8.3 Hz, 1H), 7.13â6.99 (m, 1H), 6.59 (d, <i>J</i> = 11.7 Hz, 1H), 6.53 (s, 1H), 6.43 (dt, <i>J</i> = 24.3, 12.8 Hz, 2H), 5.97 (d, <i>J</i> = 22.8 Hz, 1H), 5.65 (d, <i>J</i> = 17.0 Hz, 1H), 5.34â5.11 (m, 1H), 4.82 (dd, <i>J</i> = 12.0, 7.3 Hz, 1H), 4.74 (dd, <i>J</i> = 13.1, 7.5 Hz, 1H), 4.37â4.19 (m, 1H), 4.16â3.93 (m, 1H), 3.92 (s, 3H), 3.89 (s, 3H), 3.82â3.43 (m, 3H), 3.34 (d, <i>J</i> = 16.3 Hz, 2H), 3.22 (d, <i>J</i> = 24.1 Hz, 2H), 2.29â2.17 (m, 4H), 2.19â1.97 (m, 4H), 1.57 (s, 9H), 1.58 (s, 9H). <i>tert</i>-Butyl 5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-6-((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidine-1-carbonyl)-2-(trifluoromethyl)pyrazolo[1,5-<i>a</i>]pyrimidine-4(7<i>H</i>)-carboxylate (0.38 g, 0.59 mmol) was dissolved in AcOH (5 mL) and heated to 150 Â°C in a microwave reactor for 2 min. The solution was neutralized by the addition of satd NaHCO<sub>3</sub> and the aqueous solution extracted with EtOAc. The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, decanted, and concentrated to yield (5-(methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a 1:1 mixture of diastereomers. The diastereomers were separated by silica gel chromatography gradient elution with 40â100% EtOAc in hexane over 20 min. ((<i>S</i>)-5-(Methoxymethyl)-7-(1-methyl-1<i>H</i>-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-<i>a</i>]pyrimidin-6-yl)((<i>S</i>)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone (<b>13j</b>) was isolated as the more polar isomer as a tan powder (0.074 g, 24% yield). <sup>1</sup>H NMR (400 MHz, 55 Â°C, CDCl<sub>3</sub>) Î´ 7.51 (d, <i>J</i> = 7.7 Hz, 1H), 7.27 (d, <i>J</i> = 8.3 Hz, 1H), 7.19 (t, <i>J</i> = 7.2 Hz 1H), 7.06 (t, <i>J</i> = 7.2 Hz 1H), 6.81 (s, 1H), 6.49 (s, 1H), 6.48 (s, 1H), 5.84 (s, 1H), 5.50 (s, 1H), 5.00 (s, 1H), 4.11 (m, 2H), 3.66 (s, 3H), 3.61 (m, 1H), 3.41 (s, 3H), 3.40 (m, 1H), 2.16 (s, 3H), 1.91 (m, 4H). <sup>13</sup>C NMR (101 MHz, CDCl<sub>3</sub>) Î´ 171.36, 165.50, 159.72, 138.72, 138.20, 136.00, 126.88, 122.34, 121.03, 119.84, 109.46, 103.14, 102.33, 101.93, 85.90, 68.29, 58.90, 53.92, 47.02, 31.55, 31.15, 29.91, 22.64, 14.08, 11.30. HPLC: purity 98%, retention time 7.16 min, Zorbax SB C18, 4.6 mm Ã 75 mm, 2.5 mL/min gradient 10â100% 95:5 MeOH in H<sub>2</sub>O (0.1% H<sub>3</sub>PO<sub>4</sub>) in 5:95 MeOH in H<sub>2</sub>O (0.1% H<sub>3</sub>PO<sub>4</sub>). HRMS: [M + 1] obsd 541.21847 calcd 541.21695. Elemental analysis: C, H, N, F theoretical % 59.99, 5.03, 15.54, 10.54; obsd % 60.00, 4.95, 15.50, 10.16. The absolute stereochemistry at the C7 position was confirmed by the X-ray structure included in the <a class="ref internalNav" href="#notes-99" aria-label="Supporting Information">Supporting Information</a>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-99"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i40"><a href="/doi/suppl/10.1021/jm201386u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40130" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40130" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Absolute stereochemistry at the C7 position confirmed by the X-ray structure. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201386u/suppl_file/jm201386u_si_001.mol">jm201386u_si_001.mol (8.85 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm201386u" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71047" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71047" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Heather J. Finlay</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ea828f8b9e828f98c48c8384868b93aa888799c4898587ca80858284c4868685938eaa888799c4898587"><span class="__cf_email__" data-cfemail="5d35383c2935382f733b3433313c241d3f302e733e3230">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="b0dadfd8de9edcdcdfc9d4f0d2ddc39ed3dfdd">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Lloyd</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#96fef3f7e2fef3e4b8f0fff8faf7efd6f4fbe5b8f5f9fbb6fcf9fef8b8fafaf9eff2d6f4fbe5b8f5f9fb"><span class="__cf_email__" data-cfemail="9ff7fafeebf7faedb1f9f6f1f3fee6dffdf2ecb1fcf0f2">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="2b4144434505474744524f6b49465805484446">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wayne Vaccaro</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander Kover</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lin Yan</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gauri Bhave</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph Prol</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tram Huynh</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rao Bhandaru</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yolanda Caringal</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John DiMarco</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jinping Gan</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tim Harper</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Huang</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary Lee Conder</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Huabin Sun</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Levesque</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Blanar</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Karnail Atwal</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ruth Wexler</span> - <span class="hlFld-Affiliation affiliation">â Departments of Discovery Chemistry, â¡Crystallography, Â§Biology and â¥Preclinical Candidate
Optimization, Bristol-Myers Squibb, Research and Development, P.O. Box 5400, Princeton, New Jersey
08543-5400, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d624e4122-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31211" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31211" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Purnima Khandelwal for NMR support and Carolyn Pommier, Michael Galella, and Doree Sitkoff for crystallography support. We also thank Robert Languish for high resolution mass spectrometry support.</p></div><div class="postAsapNotesSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="postAsapNotesSection">Note Added After ASAP Publication</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">After this paper was published online March 21, 2012, a correction was made to the TOC graphic and abstract graphic. The corrected version was reposted March 23, 2012.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i42" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i42"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i43" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i43"> Abbreviations Used</h2><tr><td class="NLM_term">AERP</td><td class="NLM_def"><p class="first last">atrial effective refractory period</p></td></tr><tr><td class="NLM_term">VERP</td><td class="NLM_def"><p class="first last">ventricular effective refractory period</p></td></tr><tr><td class="NLM_term">AF</td><td class="NLM_def"><p class="first last">atrial fibrillation</p></td></tr><tr><td class="NLM_term">GSH</td><td class="NLM_def"><p class="first last">glutathione</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62587" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62587" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 25 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Go, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D.</span><span> </span><span class="NLM_article-title">Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">â</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2001&pages=2370-2375&author=A.+Goauthor=E.+Hylekauthor=K.+Phillipsauthor=Y.+Changauthor=L.+Henaultauthor=J.+Selbyauthor=D.+Singer&title=Prevalence+of+diagnosed+atrial+fibrillation+in+adults%3A+national+implications+for+rhythm+management+and+stroke+prevention%3A+the+AnTicoagulation+and+Risk+Factors+in+Atrial+Fibrillation+%28ATRIA%29+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DA.%26aulast%3DHylek%26aufirst%3DE.%26aulast%3DPhillips%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DHenault%26aufirst%3DL.%26aulast%3DSelby%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520diagnosed%2520atrial%2520fibrillation%2520in%2520adults%253A%2520national%2520implications%2520for%2520rhythm%2520management%2520and%2520stroke%2520prevention%253A%2520the%2520AnTicoagulation%2520and%2520Risk%2520Factors%2520in%2520Atrial%2520Fibrillation%2520%2528ATRIA%2529%2520Study%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2001%26volume%3D285%26spage%3D2370%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Miyasaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gersh, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abhayaratna, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seward, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. S. M.</span><span> </span><span class="NLM_article-title">Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2006&pages=119-125&author=Y.+Miyasakaauthor=M.+E.+Barnesauthor=B.+J.+Gershauthor=S.+S.+Chaauthor=K.+R.+Baileyauthor=W.+P.+Abhayaratnaauthor=J.+B.+Sewardauthor=T.+S.+M.+Tsang&title=Secular+trends+in+incidence+of+atrial+fibrillation+in+Olmsted+County%2C+Minnesota%2C+1980+to+2000%2C+and+implications+on+the+projections+for+future+prevalence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyasaka%26aufirst%3DY.%26aulast%3DBarnes%26aufirst%3DM.%2BE.%26aulast%3DGersh%26aufirst%3DB.%2BJ.%26aulast%3DCha%26aufirst%3DS.%2BS.%26aulast%3DBailey%26aufirst%3DK.%2BR.%26aulast%3DAbhayaratna%26aufirst%3DW.%2BP.%26aulast%3DSeward%26aufirst%3DJ.%2BB.%26aulast%3DTsang%26aufirst%3DT.%2BS.%2BM.%26atitle%3DSecular%2520trends%2520in%2520incidence%2520of%2520atrial%2520fibrillation%2520in%2520Olmsted%2520County%252C%2520Minnesota%252C%25201980%2520to%25202000%252C%2520and%2520implications%2520on%2520the%2520projections%2520for%2520future%2520prevalence%26jtitle%3DCirculation%26date%3D2006%26volume%3D114%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Hart, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halperin, J. L.</span><span> </span><span class="NLM_article-title">Atrial fibrillation and stroke: concepts and controversies</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">â</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=803-808&author=R.+G.+Hartauthor=J.+L.+Halperin&title=Atrial+fibrillation+and+stroke%3A+concepts+and+controversies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DR.%2BG.%26aulast%3DHalperin%26aufirst%3DJ.%2BL.%26atitle%3DAtrial%2520fibrillation%2520and%2520stroke%253A%2520concepts%2520and%2520controversies%26jtitle%3DStroke%26date%3D2001%26volume%3D32%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Janko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwarth, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span> </span><span class="NLM_article-title">Pharmacotherapy of atrial fibrillation: an old option with new possibilities</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1517%2F14656566.9.6.913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=18377335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktV2ju78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=913-925&author=S.+Jankoauthor=U.+Dorwarthauthor=E.+Hoffmann&title=Pharmacotherapy+of+atrial+fibrillation%3A+an+old+option+with+new+possibilities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy of atrial fibrillation: an old option with new possibilities</span></div><div class="casAuthors">Janko, Sabine; Dorwarth, Uwe; Hoffmann, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">913-925</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Atrial fibrillation is the most common sustained arrhythmia obsd. worldwide.  Despite modern ablative treatment options, pharmacotherapy remains the first-line therapy in patients with atrial fibrillation.  Based on recently published guidelines for the management of atrial fibrillation, the present paper reviews the current and emerging concepts of pharmacotherapy in atrial fibrillation.  A MEDLINE search was conducted using the keyword atrial fibrillation' and drug therapy'.  The reviewed literature included clin. trials and published reviews as well as clin. guidelines.  The mainstay of atrial fibrillation therapy is the prevention of thromboembolic events.  With growing knowledge of the pathophysiol. of atrial fibrillation new drug targets have been identified that promise improved outcomes in atrial fibrillation management and this will allow individual drug treatment in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonVXVW-GkzXLVg90H21EOLACvtfcHk0lhT3QDXg6eebQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktV2ju78%253D&md5=8e7d55fc6ab2429785a6ba7b62086b91</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14656566.9.6.913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.9.6.913%26sid%3Dliteratum%253Aachs%26aulast%3DJanko%26aufirst%3DS.%26aulast%3DDorwarth%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DE.%26atitle%3DPharmacotherapy%2520of%2520atrial%2520fibrillation%253A%2520an%2520old%2520option%2520with%2520new%2520possibilities%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2008%26volume%3D9%26spage%3D913%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Sven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karle, C. A.</span><span> </span><span class="NLM_article-title">The novel antiarrhythmic drug dronedarone: comparison with amiodarone</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">â</span> <span class="NLM_lpage">230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=217-230&author=K.+Svenauthor=T.+Dierkauthor=C.+A.+Karle&title=The+novel+antiarrhythmic+drug+dronedarone%3A+comparison+with+amiodarone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSven%26aufirst%3DK.%26aulast%3DDierk%26aufirst%3DT.%26aulast%3DKarle%26aufirst%3DC.%2BA.%26atitle%3DThe%2520novel%2520antiarrhythmic%2520drug%2520dronedarone%253A%2520comparison%2520with%2520amiodarone%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2005%26volume%3D23%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Chong, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, B. T.</span><span> </span><span class="NLM_article-title">Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent</span> <span class="citation_source-journal">HeartDrug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=320-331&author=P.+H.+Chongauthor=F.+Coryauthor=B.+T.+Yim&title=Treatment+of+Atrial+Fibrillation+and+Flutter%3A+Focus+on+Oral+Dofetilide%2C+a+New+Selective+Class+III+Antiarrhythmic+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DP.%2BH.%26aulast%3DCory%26aufirst%3DF.%26aulast%3DYim%26aufirst%3DB.%2BT.%26atitle%3DTreatment%2520of%2520Atrial%2520Fibrillation%2520and%2520Flutter%253A%2520Focus%2520on%2520Oral%2520Dofetilide%252C%2520a%2520New%2520Selective%2520Class%2520III%2520Antiarrhythmic%2520Agent%26jtitle%3DHeartDrug%26date%3D2001%26volume%3D1%26spage%3D320%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nattel, S.</span><span> </span><span class="NLM_article-title">Mechanism of flecainideâs antiarrhythmic action in experimental atrial fibrillation</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=271-287&author=Z.+Wangauthor=P.+Pageauthor=S.+Nattel&title=Mechanism+of+flecainide%E2%80%99s+antiarrhythmic+action+in+experimental+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DNattel%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520flecainide%25E2%2580%2599s%2520antiarrhythmic%2520action%2520in%2520experimental%2520atrial%2520fibrillation%26jtitle%3DCirc.%2520Res.%26date%3D1992%26volume%3D71%26spage%3D271%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hohnloser, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baedeker, F.</span><span> </span><span class="NLM_article-title">Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">â</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1016%2F0735-1097%2895%2900286-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=7560608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVSls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=852-858&author=S.+H.+Hohnloserauthor=A.+van+de+Looauthor=F.+Baedeker&title=Efficacy+and+proarrhythmic+hazards+of+pharmacologic+cardioversion+of+atrial+fibrillation%3A+prospective+comparison+of+sotalol+versus+quinidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine</span></div><div class="casAuthors">Hohnloser, Stefan H.; van de Loo, Andreas; Baedeker, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">852-8</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study compared the efficacy and safety of sotalol and quinidine for conversion and prevention of recurrent atrial fibrillation.  Atrial fibrillation is the most common arrhythmia.  Pharmacol. therapy has been advocated for both immediate restoration of sinus rhythm and prevention of recurrent atrial fibrillation.  Quinidine is the therapeutic mainstay for both purposes, but its safety has recently been questioned.  Although sotalol has been used successfully to maintain sinus rhythm after d.c. cardioversion, its efficacy in pharmacol. reverting atrial fibrillation has not been examd.  Fifty consecutive patients with persistent atrial fibrillation were randomized to receive quinidine or sotalol for up to 7 days to restore sinus rhythm.  Patients were followed up for 6 mo.  Quinidine was more effective than sotalol in terminating atrial fibrillation (60% vs. 20%, p = 0.009).  When nonresponders to drug therapy underwent subsequent d.c. cardioversion, total conversion rates in the quinidine and sotalol groups were comparable (88% vs. 68%, p = 0.17), as was the efficacy of the two drugs in preventing recurrent atrial fibrillation.  Side effects necessitating drug discontinuation were more often obsd. with quinidine.  No patient receiving sotalol but four patients receiving quinidine had drug-assocd. arrhythmia (torsade de pointes in three patients, sustained ventricular tachycardia in one patient).  Precordial QT dispersion detd. on the surface ECG increased with quinidine (mean Â± SD 34 Â± 9 vs. 44 Â± 16 ms,p = 0.02), indicating enhanced inhomogeneity in ventricular repolarization.  There was no change in QT dispersion in patients receiving sotalol (36 Â± 18 vs. 40 Â± 17 ms, p = 0.44).  Quinidine is more effective than sotalol in terminating atrial fibrillation but is assocd. with more side effects.  The proarrhythmic risk may be related to quinidine's propensity to increase disparity in ventricular repolarization.  This risk warrants careful ECG monitoring during the 1st 4 to 7 days of therapy.  Because most proarrhythmic effects occurred shortly after restoration of sinus rhythm, observation should continue â¥2 to 3 days after sinus rhythm is reestablished.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplSwj57GJs0bVg90H21EOLACvtfcHk0lhT3QDXg6eebQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVSls7c%253D&md5=8bb6700fea1e5258f4d87acbca0e0b86</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0735-1097%2895%2900286-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0735-1097%252895%252900286-5%26sid%3Dliteratum%253Aachs%26aulast%3DHohnloser%26aufirst%3DS.%2BH.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DA.%26aulast%3DBaedeker%26aufirst%3DF.%26atitle%3DEfficacy%2520and%2520proarrhythmic%2520hazards%2520of%2520pharmacologic%2520cardioversion%2520of%2520atrial%2520fibrillation%253A%2520prospective%2520comparison%2520of%2520sotalol%2520versus%2520quinidine%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D1995%26volume%3D26%26spage%3D852%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">De Bruin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoes, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leufkens, H. G.</span><span> </span><span class="NLM_article-title">QTc-Prolonging Drugs and Hospitalizations for Cardiac Arrhythmias</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=59-62&author=M.+L.+De+Bruinauthor=A.+W.+Hoesauthor=H.+G.+Leufkens&title=QTc-Prolonging+Drugs+and+Hospitalizations+for+Cardiac+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruin%26aufirst%3DM.%2BL.%26aulast%3DHoes%26aufirst%3DA.%2BW.%26aulast%3DLeufkens%26aufirst%3DH.%2BG.%26atitle%3DQTc-Prolonging%2520Drugs%2520and%2520Hospitalizations%2520for%2520Cardiac%2520Arrhythmias%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2003%26volume%3D91%26spage%3D59%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nattel, S.</span><span> </span><span class="NLM_article-title">New ideas about atrial fibrillation 50 years on</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=219-226&author=S.+Nattel&title=New+ideas+about+atrial+fibrillation+50+years+on"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNattel%26aufirst%3DS.%26atitle%3DNew%2520ideas%2520about%2520atrial%2520fibrillation%252050%2520years%2520on%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ford, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milnes, J. T.</span><span> </span><span class="NLM_article-title">New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=105-120&issue=2&author=J.+W.+Fordauthor=J.+T.+Milnes&title=New+Drugs+Targeting+the+Cardiac+Ultra-Rapid+Delayed-Rectifier+Current+%28IKur%29%3A+Rationale%2C+Pharmacology+and+Evidence+for+Potential+Therapeutic+Value"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DJ.%2BW.%26aulast%3DMilnes%26aufirst%3DJ.%2BT.%26atitle%3DNew%2520Drugs%2520Targeting%2520the%2520Cardiac%2520Ultra-Rapid%2520Delayed-Rectifier%2520Current%2520%2528IKur%2529%253A%2520Rationale%252C%2520Pharmacology%2520and%2520Evidence%2520for%2520Potential%2520Therapeutic%2520Value%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2008%26volume%3D52%26issue%3D2%26spage%3D105%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Lloyd, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prol, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandaru, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5469</span><span class="NLM_x">â</span> <span class="NLM_lpage">5473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5469-5473&issue=18&author=J+Lloydauthor=H.+J.+Finlayauthor=K+Atwalauthor=A+Koverauthor=J+Prolauthor=L+Yanauthor=R+Bhandaruauthor=W+Vaccaroauthor=T+Huynhauthor=C.+S.+Huangauthor=M+Conderauthor=T+Jenkins-Westauthor=H+Sunauthor=D+Liauthor=P.+Levesque&title=Dihydropyrazolopyrimidines+containing+benzimidazoles+as+KV1.5+potassium+channel+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DJ%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DAtwal%26aufirst%3DK%26aulast%3DKover%26aufirst%3DA%26aulast%3DProl%26aufirst%3DJ%26aulast%3DYan%26aufirst%3DL%26aulast%3DBhandaru%26aufirst%3DR%26aulast%3DVaccaro%26aufirst%3DW%26aulast%3DHuynh%26aufirst%3DT%26aulast%3DHuang%26aufirst%3DC.%2BS.%26aulast%3DConder%26aufirst%3DM%26aulast%3DJenkins-West%26aufirst%3DT%26aulast%3DSun%26aufirst%3DH%26aulast%3DLi%26aufirst%3DD%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DDihydropyrazolopyrimidines%2520containing%2520benzimidazoles%2520as%2520KV1.5%2520potassium%2520channel%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D18%26spage%3D5469%26epage%3D5473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Lloyd, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacarro, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyunh, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandaru, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1436</span><span class="NLM_x">â</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1436-1439&issue=4&author=J+Lloydauthor=H.+J.+Finlayauthor=W+Vacarroauthor=T+Hyunhauthor=A+Koverauthor=R+Bhandaruauthor=L+Yanauthor=K+Atwalauthor=M+Conderauthor=T+Jenkins-Westauthor=H.+Shiauthor=C+Huangauthor=D+Liauthor=H+Sunauthor=P.+Levesque&title=Pyrrolidine+amides+of+pyrazolodihydropyrimidines+as+potent+and+selective+KV1.5+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DJ%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DVacarro%26aufirst%3DW%26aulast%3DHyunh%26aufirst%3DT%26aulast%3DKover%26aufirst%3DA%26aulast%3DBhandaru%26aufirst%3DR%26aulast%3DYan%26aufirst%3DL%26aulast%3DAtwal%26aufirst%3DK%26aulast%3DConder%26aufirst%3DM%26aulast%3DJenkins-West%26aufirst%3DT%26aulast%3DShi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC%26aulast%3DLi%26aufirst%3DD%26aulast%3DSun%26aufirst%3DH%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DPyrrolidine%2520amides%2520of%2520pyrazolodihydropyrimidines%2520as%2520potent%2520and%2520selective%2520KV1.5%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D4%26spage%3D1436%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Vacarro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Dihydropyrazolopyrimidine inhibitors of KV1.5 (I Kur)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">I18</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6381</span><span class="NLM_x">â</span> <span class="NLM_lpage">6385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=I18&publication_year=2008&pages=6381-6385&issue=24&author=W.+Vacarroauthor=T.+Huynhauthor=J.+Lloydauthor=K.+S.+Atwalauthor=H.+J.+Finlayauthor=P.+C.+Levesqueauthor=M.+L.+Conderauthor=T.+Jenkins-Westauthor=H.+Shiauthor=L.+Sun&title=Dihydropyrazolopyrimidine+inhibitors+of+KV1.5+%28I+Kur%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacarro%26aufirst%3DW.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DJenkins-West%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDihydropyrazolopyrimidine%2520inhibitors%2520of%2520KV1.5%2520%2528I%2520Kur%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3DI18%26issue%3D24%26spage%3D6381%26epage%3D6385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Compounds incubated (100 Î¼M) at 37 Â°C for 30 min in 0.1 M potassium phosphate buffer containing 2 mM NADPH, 2 mM dansyl glutathione, and 2 mg/mL human liver microsomes.  The reaction was quenched with 2 volumes of 5 mM dithiothreitol in methanol then vortexed and centrifuged. 60 Î¼L of the supernatant was analyzed by HPLC equipped with a fluorescence detector (Ex = 340 nm, Em = 525 nm).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansette, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girault, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginderow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mornon, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansuy, D.</span><span> </span><span class="NLM_article-title">Chemical and Biological Oxidation of Thiophene: Preparation and Complete Characterization of Thiophene <i>S</i>-Oxide Dimers and Evidence for Thiophene <i>S</i>-Oxide as an Intermediate in Thiophene Metabolism in Vivo and in Vitro</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">â</span> <span class="NLM_lpage">1571</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja962466g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=1565-1571&author=A.+Treiberauthor=P.+M.+Dansetteauthor=E.+Hamidauthor=J.-P.+Giraultauthor=D.+Ginderowauthor=J.-P.+Mornonauthor=D.+Mansuy&title=Chemical+and+Biological+Oxidation+of+Thiophene%3A+Preparation+and+Complete+Characterization+of+Thiophene+S-Oxide+Dimers+and+Evidence+for+Thiophene+S-Oxide+as+an+Intermediate+in+Thiophene+Metabolism+in+Vivo+and+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja962466g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja962466g%26sid%3Dliteratum%253Aachs%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DDansette%26aufirst%3DP.%2BM.%26aulast%3DHamid%26aufirst%3DE.%26aulast%3DGirault%26aufirst%3DJ.-P.%26aulast%3DGinderow%26aufirst%3DD.%26aulast%3DMornon%26aufirst%3DJ.-P.%26aulast%3DMansuy%26aufirst%3DD.%26atitle%3DChemical%2520and%2520Biological%2520Oxidation%2520of%2520Thiophene%253A%2520Preparation%2520and%2520Complete%2520Characterization%2520of%2520Thiophene%2520S-Oxide%2520Dimers%2520and%2520Evidence%2520for%2520Thiophene%2520S-Oxide%2520as%2520an%2520Intermediate%2520in%2520Thiophene%2520Metabolism%2520in%2520Vivo%2520and%2520in%2520Vitro%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D1565%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Nassar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Anaya, A.</span><span> </span><span class="NLM_article-title">Strategies for dealing with reactive intermediates in drug discovery and development</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">â</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=14982156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvFOnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=126-136&author=A.+F.+Nassarauthor=A.+Lopez-Anaya&title=Strategies+for+dealing+with+reactive+intermediates+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for dealing with reactive intermediates in drug discovery and development</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Lopez-Anaya, Arturo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-136</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Idiosyncratic drug reactions (IDRs; a specific type of drug toxicity characterized by delayed onset) are a major complication of drug therapy that need to be addressed during drug discovery and development.  Efforts to improve drug safety are hampered by the lack of an accepted approach to predict IDRs, which in turn is due to the low incidence of occurrence of IDRs and the various potential mechanisms involved in these reactions.  The concept of the relative rarity and formation of reactive metabolite of IDRs is briefly described.  Hypothetical chem. mechanisms for the formation of reactive metabolites are summarized, including a classification of adverse drug reactions and types of reactive metabolites.  The relative merits of current and potential strategies for dealing with reactive intermediates in drug discovery and development are examd., and the significance of covalent binding in drug discovery/development in vitro and in vivo systems is considered.  Also discussed are the merits of tools (screening methods to trap reactive intermediates, enzyme inhibition and covalent binding) and strategies for predicting which new drugs have the potential to produce reactive intermediates and IDRs; these approaches may be considered to have the potential to improve the overall safety profile of drug candidates at various stages of the drug discovery and development process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkBgR4sVvEtLVg90H21EOLACvtfcHk0lhkheYtFb8kgQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvFOnurs%253D&md5=b1164d34fe9c7d1dd4d0e6c5063b6974</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.%2BF.%26aulast%3DLopez-Anaya%26aufirst%3DA.%26atitle%3DStrategies%2520for%2520dealing%2520with%2520reactive%2520intermediates%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D126%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Reimlinger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Overstraeten, A.</span><span> </span><span class="NLM_article-title">Reactions of 3(5)-diazopyrazole. II</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3350</span><span class="NLM_x">â</span> <span class="NLM_lpage">3357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1966&pages=3350-3357&author=H.+Reimlingerauthor=A.+Van+Overstraeten&title=Reactions+of+3%285%29-diazopyrazole.+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReimlinger%26aufirst%3DH.%26aulast%3DVan%2BOverstraeten%26aufirst%3DA.%26atitle%3DReactions%2520of%25203%25285%2529-diazopyrazole.%2520II%26jtitle%3DChem.%2520Ber.%26date%3D1966%26volume%3D99%26spage%3D3350%26epage%3D3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Kirk, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. A.</span><span> </span><span class="NLM_article-title">Photochemistry of diazonium salts. I. Synthesis of 4-fluoroimidazoles, 4-fluorohistamine, and 4-fluorohistidine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">â</span> <span class="NLM_lpage">4624</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00795a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=4619-4624&author=K.+L.+Kirkauthor=L.+A.+Cohen&title=Photochemistry+of+diazonium+salts.+I.+Synthesis+of+4-fluoroimidazoles%2C+4-fluorohistamine%2C+and+4-fluorohistidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00795a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00795a026%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DCohen%26aufirst%3DL.%2BA.%26atitle%3DPhotochemistry%2520of%2520diazonium%2520salts.%2520I.%2520Synthesis%2520of%25204-fluoroimidazoles%252C%25204-fluorohistamine%252C%2520and%25204-fluorohistidine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D4619%26epage%3D4624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Janssen, J. W. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeners, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habraken, C. L.</span><span> </span><span class="NLM_article-title">Pyrazoles. XII. Preparation of 3(5)-nitropyrazoles by thermal rearrangement of <i>N</i>-nitropyrazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1777</span><span class="NLM_x">â</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00950a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=1777-1782&author=J.+W.+A.+M.+Janssenauthor=H.+J.+Koenersauthor=C.+G.+Kruseauthor=C.+L.+Habraken&title=Pyrazoles.+XII.+Preparation+of+3%285%29-nitropyrazoles+by+thermal+rearrangement+of+N-nitropyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo00950a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00950a001%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%2BA.%2BM.%26aulast%3DKoeners%26aufirst%3DH.%2BJ.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3DHabraken%26aufirst%3DC.%2BL.%26atitle%3DPyrazoles.%2520XII.%2520Preparation%2520of%25203%25285%2529-nitropyrazoles%2520by%2520thermal%2520rearrangement%2520of%2520N-nitropyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D1777%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Ligands for Brain Cholinergic Channel Receptors: Synthesis and in Vitro Characterization of Novel Isoxazoles and Isothiazoles as Bioisosteric Replacements for the Pyridine Ring in Nicotine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4455</span><span class="NLM_x">â</span> <span class="NLM_lpage">4463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00052a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4455-4463&issue=26&author=D.+S.+Garveyauthor=J.+T.+Wasicakauthor=R.+L.+Elliottauthor=S.+Leboldauthor=A.+Hettingerauthor=G.+M.+Carreraauthor=N.+Linauthor=Y.+Heauthor=M.+W.+Holladay&title=Ligands+for+Brain+Cholinergic+Channel+Receptors%3A+Synthesis+and+in+Vitro+Characterization+of+Novel+Isoxazoles+and+Isothiazoles+as+Bioisosteric+Replacements+for+the+Pyridine+Ring+in+Nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00052a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00052a005%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DLebold%26aufirst%3DS.%26aulast%3DHettinger%26aufirst%3DA.%26aulast%3DCarrera%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DLigands%2520for%2520Brain%2520Cholinergic%2520Channel%2520Receptors%253A%2520Synthesis%2520and%2520in%2520Vitro%2520Characterization%2520of%2520Novel%2520Isoxazoles%2520and%2520Isothiazoles%2520as%2520Bioisosteric%2520Replacements%2520for%2520the%2520Pyridine%2520Ring%2520in%2520Nicotine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D26%26spage%3D4455%26epage%3D4463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Synders, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamakun, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, P. B.</span><span> </span><span class="NLM_article-title">A rapidly activating and slowly inactivating potassium channel cloned from human heart: functional analysis after stable mammalian cell culture expression</span> <span class="citation_source-journal">J. Gen. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1993&pages=513-543&author=D.+J.+Syndersauthor=M.+N.+Tamakunauthor=P.+B.+Bennett&title=A+rapidly+activating+and+slowly+inactivating+potassium+channel+cloned+from+human+heart%3A+functional+analysis+after+stable+mammalian+cell+culture+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSynders%26aufirst%3DD.%2BJ.%26aulast%3DTamakun%26aufirst%3DM.%2BN.%26aulast%3DBennett%26aufirst%3DP.%2BB.%26atitle%3DA%2520rapidly%2520activating%2520and%2520slowly%2520inactivating%2520potassium%2520channel%2520cloned%2520from%2520human%2520heart%253A%2520functional%2520analysis%2520after%2520stable%2520mammalian%2520cell%2520culture%2520expression%26jtitle%3DJ.%2520Gen.%2520Physiol.%26date%3D1993%26volume%3D101%26spage%3D513%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vorperian, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">and January, C.T. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole</span> <span class="citation_source-journal">J. Cardiovasc. Electrophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">836</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=836-843&issue=6&author=Z.+Zhouauthor=V.+R.+Vorperianauthor=Q.+Gongauthor=S.+Zhang&title=and+January%2C+C.T.+Block+of+HERG+potassium+channels+by+the+antihistamine+astemizole+and+its+metabolites+desmethylastemizole+and+norastemizole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DVorperian%26aufirst%3DV.%2BR.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3Dand%2520January%252C%2520C.T.%2520Block%2520of%2520HERG%2520potassium%2520channels%2520by%2520the%2520antihistamine%2520astemizole%2520and%2520its%2520metabolites%2520desmethylastemizole%2520and%2520norastemizole%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D1999%26volume%3D10%26issue%3D6%26spage%3D836%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety</span> <span class="citation_source-journal">Cardiovasc. Hematol. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">64</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=64-75&issue=1&author=D.+Liauthor=H.+Sunauthor=P.+Levesque&title=Antiarrhythmic+drug+therapy+for+atrial+fibrillation%3A+focus+on+atrial+selectivity+and+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DAntiarrhythmic%2520drug%2520therapy%2520for%2520atrial%2520fibrillation%253A%2520focus%2520on%2520atrial%2520selectivity%2520and%2520safety%26jtitle%3DCardiovasc.%2520Hematol.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D7%26issue%3D1%26spage%3D64%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Carlsson, Leif.</span><span> </span><span class="NLM_article-title">The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">â</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1016%2Fj.pharmthera.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=18558435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKntrnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2008&pages=160-167&issue=2&author=Leif.+Carlsson&title=The+anaesthetised+methoxamine-sensitised+rabbit+model+of+torsades+de+pointes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes</span></div><div class="casAuthors">Carlsson, Leif</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-167</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Current guidelines describe strategies on how the potential of non-antiarrhythmic drugs to delay ventricular repolarisation should be assessed.  However, the non-clin. guidelines recommend repolarisation assays only and do not advocate exptl. models that express the proarrhythmia of concern, torsades de pointes (TdP).  Although the repolarisation assays may predict QT interval prolongation in man they cannot alone sufficiently predict proarrhythmia risk.  Furthermore, there is also a need for more robust surrogate markers of drug-induced proarrhythmia and such validated markers are on the horizon as a result of the availability of sensitive animal models of TdP.  This review will describe the methoxamine-sensitized rabbit model of TdP, one of the most frequently used proarrhythmia models, and present some of it characteristics, its pros and cons and how it historically has been used for assessing proarrhythmia liability of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUJSRwevXy7Vg90H21EOLACvtfcHk0lhyaHi66EytrA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKntrnE&md5=80b12489e03cb25cafb3417768d0e0d6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DLeif.%26atitle%3DThe%2520anaesthetised%2520methoxamine-sensitised%2520rabbit%2520model%2520of%2520torsades%2520de%2520pointes%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D119%26issue%3D2%26spage%3D160%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':[],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jean Quancard, Oliver Simic, Carole Pissot Soldermann, Reiner Aichholz, Markus Blatter, Martin Renatus, Paulus Erbel, Samu Melkko, Ralf Endres, Mickael Sorge, Laurence Kieffer, Trixie Wagner, Karen Beltz, Paul Mcsheehy, Markus Wartmann, Catherine H. RÃ©gnier, Thomas Calzascia, Thomas Radimerski, Marc Bigaud, Andreas Weiss, FrÃ©dÃ©ric Bornancin, <span class="NLM_string-name hlFld-ContribAuthor">Achim Schlapbach</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of the In Vivo Potency of Pyrazolopyrimidine MALT1 Protease Inhibitors by Reducing Metabolism and Increasing Potency in Whole Blood. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (23)
                                     , 14594-14608. <a href="https://doi.org/10.1021/acs.jmedchem.0c01246" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01246</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01246%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bthe%252BIn%252BVivo%252BPotency%252Bof%252BPyrazolopyrimidine%252BMALT1%252BProtease%252BInhibitors%252Bby%252BReducing%252BMetabolism%252Band%252BIncreasing%252BPotency%252Bin%252BWhole%252BBlood%26aulast%3DQuancard%26aufirst%3DJean%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D17072020%26date%3D20112020%26volume%3D63%26issue%3D23%26spage%3D14594%26epage%3D14608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.E.  Huseynzada</span>, <span class="hlFld-ContribAuthor ">C.  Jelsch</span>, <span class="hlFld-ContribAuthor ">H.N.  Akhundzada</span>, <span class="hlFld-ContribAuthor ">S.  Soudani</span>, <span class="hlFld-ContribAuthor ">C. Ben  Nasr</span>, <span class="hlFld-ContribAuthor ">F.  Doria</span>, <span class="hlFld-ContribAuthor ">U.A.  Hasanova</span>, <span class="hlFld-ContribAuthor ">M.  Freccero</span>, <span class="hlFld-ContribAuthor ">Z.  Gakhramanova</span>, <span class="hlFld-ContribAuthor ">K.  Ganbarov</span>, <span class="hlFld-ContribAuthor ">B.  Najafov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and antibacterial studies of 2,4,6-trimetoxybenzaldehyde based dihydropyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1241 </em>, 130678. <a href="https://doi.org/10.1016/j.molstruc.2021.130678" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.130678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.130678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.130678%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bantibacterial%252Bstudies%252Bof%252B2%25252C4%25252C6-trimetoxybenzaldehyde%252Bbased%252Bdihydropyrimidine%252Bderivatives%26aulast%3DHuseynzada%26aufirst%3DA.E.%26date%3D2021%26volume%3D1241%26spage%3D130678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alakbar E.  Huseynzada</span>, <span class="hlFld-ContribAuthor ">Christian  Jelch</span>, <span class="hlFld-ContribAuthor ">Haji Vahid N.  Akhundzada</span>, <span class="hlFld-ContribAuthor ">Sarra  Soudani</span>, <span class="hlFld-ContribAuthor ">Cherif  Ben Nasr</span>, <span class="hlFld-ContribAuthor ">Aygun  Israyilova</span>, <span class="hlFld-ContribAuthor ">Filippo  Doria</span>, <span class="hlFld-ContribAuthor ">Ulviyya A.  Hasanova</span>, <span class="hlFld-ContribAuthor ">Rana F.  Khankishiyeva</span>, <span class="hlFld-ContribAuthor ">Mauro  Freccero</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and antibacterial studies of dihydropyrimidines and their regioselectively oxidized products. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (11)
                                     , 6312-6329. <a href="https://doi.org/10.1039/D0RA10255E" title="DOI URL">https://doi.org/10.1039/D0RA10255E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA10255E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA10255E%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bantibacterial%252Bstudies%252Bof%252Bdihydropyrimidines%252Band%252Btheir%252Bregioselectively%252Boxidized%252Bproducts%26aulast%3DHuseynzada%26aufirst%3DAlakbar%2BE.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D11%26spage%3D6312%26epage%3D6329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.E.  Huseynzada</span>, <span class="hlFld-ContribAuthor ">C.  Jelsch</span>, <span class="hlFld-ContribAuthor ">H.N.  Akhundzada</span>, <span class="hlFld-ContribAuthor ">S.  Soudani</span>, <span class="hlFld-ContribAuthor ">C.  Ben Nasr</span>, <span class="hlFld-ContribAuthor ">F.  Doria</span>, <span class="hlFld-ContribAuthor ">U.A.  Hasanova</span>, <span class="hlFld-ContribAuthor ">M.  Freccero</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, crystal structure and antibacterial properties of 6-methyl-2-oxo-4-(quinolin-2-yl)-1,2,3,4-tetrahydropyrimidine-5-carboxylate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1219 </em>, 128581. <a href="https://doi.org/10.1016/j.molstruc.2020.128581" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.128581</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.128581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.128581%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DSynthesis%25252C%252Bcrystal%252Bstructure%252Band%252Bantibacterial%252Bproperties%252Bof%252B6-methyl-2-oxo-4-%252528quinolin-2-yl%252529-1%25252C2%25252C3%25252C4-tetrahydropyrimidine-5-carboxylate%26aulast%3DHuseynzada%26aufirst%3DA.E.%26date%3D2020%26volume%3D1219%26spage%3D128581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zefeng  Zhao</span>, <span class="hlFld-ContribAuthor ">Songsong  Ruan</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Ma</span>, <span class="hlFld-ContribAuthor ">Qian  Feng</span>, <span class="hlFld-ContribAuthor ">Zhuosong  Xie</span>, <span class="hlFld-ContribAuthor ">Zhuang  Nie</span>, <span class="hlFld-ContribAuthor ">Peinan  Fan</span>, <span class="hlFld-ContribAuthor ">Mingcheng  Qian</span>, <span class="hlFld-ContribAuthor ">Xirui  He</span>, <span class="hlFld-ContribAuthor ">Shaoping  Wu</span>, <span class="hlFld-ContribAuthor ">Yongmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zheng</span>. </span><span class="cited-content_cbyCitation_article-title">Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 10. <a href="https://doi.org/10.3390/biom10010010" title="DOI URL">https://doi.org/10.3390/biom10010010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10010010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10010010%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DChallenges%252BFaced%252Bwith%252BSmall%252BMolecular%252BModulators%252Bof%252BPotassium%252BCurrent%252BChannel%252BIsoform%252BKv1.5%26aulast%3DZhao%26aufirst%3DZefeng%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ahmad  Shaabani</span>, <span class="hlFld-ContribAuthor ">Mohammad Taghi  Nazeri</span>, <span class="hlFld-ContribAuthor ">Ronak  Afshari</span>. </span><span class="cited-content_cbyCitation_article-title">5-Amino-pyrazoles: potent reagents in organic and medicinal synthesis. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2019,</strong> <em>23 </em>
                                    (3)
                                     , 751-807. <a href="https://doi.org/10.1007/s11030-018-9902-8" title="DOI URL">https://doi.org/10.1007/s11030-018-9902-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-018-9902-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-018-9902-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3D5-Amino-pyrazoles%25253A%252Bpotent%252Breagents%252Bin%252Borganic%252Band%252Bmedicinal%252Bsynthesis%26aulast%3DShaabani%26aufirst%3DAhmad%26date%3D2019%26date%3D2018%26volume%3D23%26issue%3D3%26spage%3D751%26epage%3D807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johan  Kajanus</span>, <span class="hlFld-ContribAuthor ">Thomas  Antonsson</span>, <span class="hlFld-ContribAuthor ">Leif  Carlsson</span>, <span class="hlFld-ContribAuthor ">Ulrik  Jurva</span>, <span class="hlFld-ContribAuthor ">Anna  Pettersen</span>, <span class="hlFld-ContribAuthor ">Johan  Sundell</span>, <span class="hlFld-ContribAuthor ">Tord  Inghardt</span>. </span><span class="cited-content_cbyCitation_article-title">Potassium channel blocking 1,2-bis(aryl)ethane-1,2-diamines active as antiarrhythmic agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (10)
                                     , 1241-1245. <a href="https://doi.org/10.1016/j.bmcl.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPotassium%252Bchannel%252Bblocking%252B1%25252C2-bis%252528aryl%252529ethane-1%25252C2-diamines%252Bactive%252Bas%252Bantiarrhythmic%252Bagents%26aulast%3DKajanus%26aufirst%3DJohan%26date%3D2019%26volume%3D29%26issue%3D10%26spage%3D1241%26epage%3D1245" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryna V.  Murlykina</span>, <span class="hlFld-ContribAuthor ">Alisa D.  Morozova</span>, <span class="hlFld-ContribAuthor ">Ievgen M.  Zviagin</span>, <span class="hlFld-ContribAuthor ">Yana I.  Sakhno</span>, <span class="hlFld-ContribAuthor ">Sergey M.  Desenko</span>, <span class="hlFld-ContribAuthor ">Valentyn A.  Chebanov</span>. </span><span class="cited-content_cbyCitation_article-title">Aminoazole-Based Diversity-Oriented Synthesis of Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00527" title="DOI URL">https://doi.org/10.3389/fchem.2018.00527</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00527%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DAminoazole-Based%252BDiversity-Oriented%252BSynthesis%252Bof%252BHeterocycles%26aulast%3DMurlykina%26aufirst%3DMaryna%2BV.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John  Lloyd</span>, <span class="hlFld-ContribAuthor ">Heather J.  Finlay</span>, <span class="hlFld-ContribAuthor ">Alexander  Kover</span>, <span class="hlFld-ContribAuthor ">James  Johnson</span>, <span class="hlFld-ContribAuthor ">Zulan  Pi</span>, <span class="hlFld-ContribAuthor ">Ji  Jiang</span>, <span class="hlFld-ContribAuthor ">James  Neels</span>, <span class="hlFld-ContribAuthor ">Cullen  Cavallaro</span>, <span class="hlFld-ContribAuthor ">Ruth  Wexler</span>, <span class="hlFld-ContribAuthor ">Mary Lee  Conder</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Anjaneya  Chimalakonda</span>, <span class="hlFld-ContribAuthor ">Christine  Huang</span>, <span class="hlFld-ContribAuthor ">Mark  Salvati</span>, <span class="hlFld-ContribAuthor ">Paul  Levesque</span>. </span><span class="cited-content_cbyCitation_article-title">Pseudosaccharin amines as potent and selective K V 1.5 blockers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (21)
                                     , 4983-4986. <a href="https://doi.org/10.1016/j.bmcl.2015.02.066" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.02.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.02.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.02.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPseudosaccharin%252Bamines%252Bas%252Bpotent%252Band%252Bselective%252BK%252BV%252B1.5%252Bblockers%26aulast%3DLloyd%26aufirst%3DJohn%26date%3D2015%26volume%3D25%26issue%3D21%26spage%3D4983%26epage%3D4986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Said  El-Haou</span>, <span class="hlFld-ContribAuthor ">John W.  Ford</span>, <span class="hlFld-ContribAuthor ">James T.  Milnes</span>. </span><span class="cited-content_cbyCitation_article-title">Novel K+ Channel Targets in Atrial Fibrillation Drug DevelopmentâWhere Are We?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology</span><span> <strong>2015,</strong> <em>66 </em>
                                    (5)
                                     , 412-431. <a href="https://doi.org/10.1097/FJC.0000000000000277" title="DOI URL">https://doi.org/10.1097/FJC.0000000000000277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/FJC.0000000000000277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FFJC.0000000000000277%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%26atitle%3DNovel%252BK%25252B%252BChannel%252BTargets%252Bin%252BAtrial%252BFibrillation%252BDrug%252BDevelopment%2525E2%252580%252594Where%252BAre%252BWe%25253F%26aulast%3DEl-Haou%26aufirst%3DSaid%26date%3D2015%26volume%3D66%26issue%3D5%26spage%3D412%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deepak  Dalvie</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>, <span class="hlFld-ContribAuthor ">Weichao  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Practical approaches to resolving reactive metabolite liabilities in early discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Metabolism Reviews</span><span> <strong>2015,</strong> <em>47 </em>
                                    (1)
                                     , 56-70. <a href="https://doi.org/10.3109/03602532.2014.984813" title="DOI URL">https://doi.org/10.3109/03602532.2014.984813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/03602532.2014.984813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F03602532.2014.984813%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Metabolism%2520Reviews%26atitle%3DPractical%252Bapproaches%252Bto%252Bresolving%252Breactive%252Bmetabolite%252Bliabilities%252Bin%252Bearly%252Bdiscovery%26aulast%3DDalvie%26aufirst%3DDeepak%26date%3D2015%26date%3D2014%26volume%3D47%26issue%3D1%26spage%3D56%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Ningning  Xu</span>, <span class="hlFld-ContribAuthor ">Yoon  Jeon</span>, <span class="hlFld-ContribAuthor ">Heather J.  Finlay</span>, <span class="hlFld-ContribAuthor ">Alexander  Kover</span>, <span class="hlFld-ContribAuthor ">Mary L.  Conder</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Paul  Levesque</span>, <span class="hlFld-ContribAuthor ">Mei-Mann  Hsueh</span>, <span class="hlFld-ContribAuthor ">Timothy W.  Harper</span>, <span class="hlFld-ContribAuthor ">Ruth R.  Wexler</span>, <span class="hlFld-ContribAuthor ">John  Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of phenethylaminoheterocycles as Kv1.5 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (14)
                                     , 3018-3022. <a href="https://doi.org/10.1016/j.bmcl.2014.05.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.05.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.05.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bphenethylaminoheterocycles%252Bas%252BKv1.5%252Binhibitors%26aulast%3DJohnson%26aufirst%3DJames%2BA.%26date%3D2014%26volume%3D24%26issue%3D14%26spage%3D3018%26epage%3D3022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoke  Guo</span>, <span class="hlFld-ContribAuthor ">Xianglei  Ma</span>, <span class="hlFld-ContribAuthor ">Qian  Yang</span>, <span class="hlFld-ContribAuthor ">Jing  Xu</span>, <span class="hlFld-ContribAuthor ">Lu  Huang</span>, <span class="hlFld-ContribAuthor ">Jianmin  Jia</span>, <span class="hlFld-ContribAuthor ">Jiaojiao  Shan</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Weilin  Chen</span>, <span class="hlFld-ContribAuthor ">Hongxi  Chu</span>, <span class="hlFld-ContribAuthor ">Jinlian  Wei</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>, <span class="hlFld-ContribAuthor ">Haopeng  Sun</span>, <span class="hlFld-ContribAuthor ">Yiqun  Tang</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 1-aryloxyethyl piperazine derivatives as Kv1.5 potassium channel inhibitors (part I). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>81 </em>, 89-94. <a href="https://doi.org/10.1016/j.ejmech.2014.03.075" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B1-aryloxyethyl%252Bpiperazine%252Bderivatives%252Bas%252BKv1.5%252Bpotassium%252Bchannel%252Binhibitors%252B%252528part%252BI%252529%26aulast%3DGuo%26aufirst%3DXiaoke%26date%3D2014%26volume%3D81%26spage%3D89%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather  Finlay</span>. </span><span class="cited-content_cbyCitation_article-title">Current Approaches to the Treatment of Atrial Fibrillation. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 101-113. <a href="https://doi.org/10.1016/B978-0-12-800167-7.00008-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-800167-7.00008-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-800167-7.00008-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-800167-7.00008-0%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BApproaches%252Bto%252Bthe%252BTreatment%252Bof%252BAtrial%252BFibrillation%26aulast%3DFinlay%26aufirst%3DHeather%26date%3D2014%26spage%3D101%26epage%3D113%26pub%3DElsevier%26date%3D2014%26volume%3D49" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Petr  CankaÅ</span>, <span class="hlFld-ContribAuthor ">LukÃ¡Å¡  JedinÃ¡k</span>, <span class="hlFld-ContribAuthor ">VladimÃ­r  KryÅ¡tof</span>, <span class="hlFld-ContribAuthor ">ZdenÄk  TrÃ¡vnÃ­Äek</span>. </span><span class="cited-content_cbyCitation_article-title">Multicomponent and Regioselective Synthesis of Dihydropyrazolo[1,5-a]pyrimidines from Aromatic Aldehydes, Meldrumâs Acid, and Aminopyrazole CAN508. </span><span class="cited-content_cbyCitation_journal-name">HETEROCYCLES</span><span> <strong>2014,</strong> <em>89 </em>
                                    (8)
                                     , 1892. <a href="https://doi.org/10.3987/COM-14-13026" title="DOI URL">https://doi.org/10.3987/COM-14-13026</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3987/COM-14-13026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3987%2FCOM-14-13026%26sid%3Dliteratum%253Aachs%26jtitle%3DHETEROCYCLES%26atitle%3DMulticomponent%252Band%252BRegioselective%252BSynthesis%252Bof%252BDihydropyrazolo%25255B1%25252C5-a%25255Dpyrimidines%252Bfrom%252BAromatic%252BAldehydes%25252C%252BMeldrum%2525E2%252580%252599s%252BAcid%25252C%252Band%252BAminopyrazole%252BCAN508%26aulast%3DCanka%25C5%2599%26aufirst%3DPetr%26date%3D2014%26volume%3D89%26issue%3D8%26spage%3D1892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ingemar  Jacobson</span>, <span class="hlFld-ContribAuthor ">GÃ¶ran  Duker</span>, <span class="hlFld-ContribAuthor ">Malin  Florentzson</span>, <span class="hlFld-ContribAuthor ">Gunilla  Linhardt</span>, <span class="hlFld-ContribAuthor ">Emma  Lindhardt</span>, <span class="hlFld-ContribAuthor ">Ann-Kristin  Nordkam</span>, <span class="hlFld-ContribAuthor ">Annika  Ãstrand</span>, <span class="hlFld-ContribAuthor ">Leif  Carlsson</span>. </span><span class="cited-content_cbyCitation_article-title">Electrophysiological Characterization and Antiarrhythmic Efficacy of the Mixed Potassium Channel-Blocking Antiarrhythmic Agent AZ13395438 In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cardiovascular Pharmacology and Therapeutics</span><span> <strong>2013,</strong> <em>18 </em>
                                    (3)
                                     , 290-300. <a href="https://doi.org/10.1177/1074248412470512" title="DOI URL">https://doi.org/10.1177/1074248412470512</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1074248412470512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1074248412470512%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cardiovascular%2520Pharmacology%2520and%2520Therapeutics%26atitle%3DElectrophysiological%252BCharacterization%252Band%252BAntiarrhythmic%252BEfficacy%252Bof%252Bthe%252BMixed%252BPotassium%252BChannel-Blocking%252BAntiarrhythmic%252BAgent%252BAZ13395438%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DJacobson%26aufirst%3DIngemar%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D3%26spage%3D290%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heather J.  Finlay</span>, <span class="hlFld-ContribAuthor ">Ji  Jiang</span>, <span class="hlFld-ContribAuthor ">Yolanda  Caringal</span>, <span class="hlFld-ContribAuthor ">Alexander  Kover</span>, <span class="hlFld-ContribAuthor ">Mary Lee  Conder</span>, <span class="hlFld-ContribAuthor ">Dezhi  Xing</span>, <span class="hlFld-ContribAuthor ">Paul  Levesque</span>, <span class="hlFld-ContribAuthor ">Timothy  Harper</span>, <span class="hlFld-ContribAuthor ">Mei Mann  Hsueh</span>, <span class="hlFld-ContribAuthor ">Karnail  Atwal</span>, <span class="hlFld-ContribAuthor ">Michael  Blanar</span>, <span class="hlFld-ContribAuthor ">Ruth  Wexler</span>, <span class="hlFld-ContribAuthor ">John  Lloyd</span>. </span><span class="cited-content_cbyCitation_article-title">Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (6)
                                     , 1743-1747. <a href="https://doi.org/10.1016/j.bmcl.2013.01.064" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.01.064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.01.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.01.064%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DTriazolo%252Band%252Bimidazo%252Bdihydropyrazolopyrimidine%252Bpotassium%252Bchannel%252Bantagonists%26aulast%3DFinlay%26aufirst%3DHeather%2BJ.%26date%3D2013%26volume%3D23%26issue%3D6%26spage%3D1743%26epage%3D1747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonia F.  Stepan</span>, <span class="hlFld-ContribAuthor ">Vincent  Mascitti</span>, <span class="hlFld-ContribAuthor ">Kevin  Beaumont</span>, <span class="hlFld-ContribAuthor ">Amit S.  Kalgutkar</span>. </span><span class="cited-content_cbyCitation_article-title">Metabolism-guided drug design. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2013,</strong> <em>4 </em>
                                    (4)
                                     , 631. <a href="https://doi.org/10.1039/c2md20317k" title="DOI URL">https://doi.org/10.1039/c2md20317k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c2md20317k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc2md20317k%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DMetabolism-guided%252Bdrug%252Bdesign%26aulast%3DStepan%26aufirst%3DAntonia%2BF.%26date%3D2013%26volume%3D4%26issue%3D4%26spage%3D631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0013.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dihydropyrazolopyrimidines which form reactive intermediates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: yields (a) DMF, NaOAc, 65 Â°C, 14 h, yield range 27â60%.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene, 120 Â°C, 4 h, 84% yield; (b) HCl, dioxane, isoamyl nitrate, â10 Â°C, 98% yield; (c) Cu(II)Cl<sub>2</sub> Cu(I)Cl, ether, MeOH, â10 Â°C, 86% yield; (d) AcOH, 90% HNO<sub>3</sub>, acetic anhydride, 0 Â°C, 32% yield; (e) anisole, 130 Â°C, 24 h, 100% yield; (f) Pd/C, hydrogen, 50 psi, 95% yield; (g) NaHCO<sub>3</sub>, DMF, 55 Â°C, 72 h, 24% yield.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DMF, NaHCO<sub>3</sub>, 65 Â°C, 24 h; (b) TMSOTf, DCM, RT; (c) EDCI, DCM, TEA, RT, 14 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) heptane, catalytic piperidine, 75 Â°C, 120 h; (b) di-<i>tert</i>-butyl carbonate, THF, DMAP, RT; (c) LiOH, THF; (d) EDCI, DCM; (e) AcOH, microwave 150 Â°C, 2 min; (f) acetone oxime, nBuLi, THF, â15 Â°C to RT; (g) H<sub>2</sub>SO<sub>4</sub>, â15 Â°C to RT, 51% yield, 2 steps; (h) TfOH, DCM RT, 42% yield.</p></p></figure><figure data-id="fig1a" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Effect on AERP and VERP in rabbit for compound <b>13e</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig1a"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last">Dose (mg/kg IV) with plasma concentration in Î¼M at each dose (<i>n</i> = 3)</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/medium/jm-2011-01386u_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0010.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect on AERP and VERP in rabbit for compound <b>13j</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-7/jm201386u/production/images/large/jm-2011-01386u_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm201386u&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i44">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14842" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14842" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 25 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Go, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hylek, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henault, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Singer, D.</span><span> </span><span class="NLM_article-title">Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study</span> <span class="citation_source-journal">JAMA, J. Am. Med. Assoc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">2370</span><span class="NLM_x">â</span> <span class="NLM_lpage">2375</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=2001&pages=2370-2375&author=A.+Goauthor=E.+Hylekauthor=K.+Phillipsauthor=Y.+Changauthor=L.+Henaultauthor=J.+Selbyauthor=D.+Singer&title=Prevalence+of+diagnosed+atrial+fibrillation+in+adults%3A+national+implications+for+rhythm+management+and+stroke+prevention%3A+the+AnTicoagulation+and+Risk+Factors+in+Atrial+Fibrillation+%28ATRIA%29+Study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGo%26aufirst%3DA.%26aulast%3DHylek%26aufirst%3DE.%26aulast%3DPhillips%26aufirst%3DK.%26aulast%3DChang%26aufirst%3DY.%26aulast%3DHenault%26aufirst%3DL.%26aulast%3DSelby%26aufirst%3DJ.%26aulast%3DSinger%26aufirst%3DD.%26atitle%3DPrevalence%2520of%2520diagnosed%2520atrial%2520fibrillation%2520in%2520adults%253A%2520national%2520implications%2520for%2520rhythm%2520management%2520and%2520stroke%2520prevention%253A%2520the%2520AnTicoagulation%2520and%2520Risk%2520Factors%2520in%2520Atrial%2520Fibrillation%2520%2528ATRIA%2529%2520Study%26jtitle%3DJAMA%252C%2520J.%2520Am.%2520Med.%2520Assoc.%26date%3D2001%26volume%3D285%26spage%3D2370%26epage%3D2375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Miyasaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gersh, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cha, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abhayaratna, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seward, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsang, T. S. M.</span><span> </span><span class="NLM_article-title">Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence</span> <span class="citation_source-journal">Circulation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">125</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2006&pages=119-125&author=Y.+Miyasakaauthor=M.+E.+Barnesauthor=B.+J.+Gershauthor=S.+S.+Chaauthor=K.+R.+Baileyauthor=W.+P.+Abhayaratnaauthor=J.+B.+Sewardauthor=T.+S.+M.+Tsang&title=Secular+trends+in+incidence+of+atrial+fibrillation+in+Olmsted+County%2C+Minnesota%2C+1980+to+2000%2C+and+implications+on+the+projections+for+future+prevalence"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMiyasaka%26aufirst%3DY.%26aulast%3DBarnes%26aufirst%3DM.%2BE.%26aulast%3DGersh%26aufirst%3DB.%2BJ.%26aulast%3DCha%26aufirst%3DS.%2BS.%26aulast%3DBailey%26aufirst%3DK.%2BR.%26aulast%3DAbhayaratna%26aufirst%3DW.%2BP.%26aulast%3DSeward%26aufirst%3DJ.%2BB.%26aulast%3DTsang%26aufirst%3DT.%2BS.%2BM.%26atitle%3DSecular%2520trends%2520in%2520incidence%2520of%2520atrial%2520fibrillation%2520in%2520Olmsted%2520County%252C%2520Minnesota%252C%25201980%2520to%25202000%252C%2520and%2520implications%2520on%2520the%2520projections%2520for%2520future%2520prevalence%26jtitle%3DCirculation%26date%3D2006%26volume%3D114%26spage%3D119%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Hart, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halperin, J. L.</span><span> </span><span class="NLM_article-title">Atrial fibrillation and stroke: concepts and controversies</span> <span class="citation_source-journal">Stroke</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">803</span><span class="NLM_x">â</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2001&pages=803-808&author=R.+G.+Hartauthor=J.+L.+Halperin&title=Atrial+fibrillation+and+stroke%3A+concepts+and+controversies"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHart%26aufirst%3DR.%2BG.%26aulast%3DHalperin%26aufirst%3DJ.%2BL.%26atitle%3DAtrial%2520fibrillation%2520and%2520stroke%253A%2520concepts%2520and%2520controversies%26jtitle%3DStroke%26date%3D2001%26volume%3D32%26spage%3D803%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Janko, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorwarth, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span> </span><span class="NLM_article-title">Pharmacotherapy of atrial fibrillation: an old option with new possibilities</span> <span class="citation_source-journal">Expert Opin. Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">925</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1517%2F14656566.9.6.913" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=18377335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXktV2ju78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2008&pages=913-925&author=S.+Jankoauthor=U.+Dorwarthauthor=E.+Hoffmann&title=Pharmacotherapy+of+atrial+fibrillation%3A+an+old+option+with+new+possibilities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacotherapy of atrial fibrillation: an old option with new possibilities</span></div><div class="casAuthors">Janko, Sabine; Dorwarth, Uwe; Hoffmann, Ellen</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">913-925</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Atrial fibrillation is the most common sustained arrhythmia obsd. worldwide.  Despite modern ablative treatment options, pharmacotherapy remains the first-line therapy in patients with atrial fibrillation.  Based on recently published guidelines for the management of atrial fibrillation, the present paper reviews the current and emerging concepts of pharmacotherapy in atrial fibrillation.  A MEDLINE search was conducted using the keyword atrial fibrillation' and drug therapy'.  The reviewed literature included clin. trials and published reviews as well as clin. guidelines.  The mainstay of atrial fibrillation therapy is the prevention of thromboembolic events.  With growing knowledge of the pathophysiol. of atrial fibrillation new drug targets have been identified that promise improved outcomes in atrial fibrillation management and this will allow individual drug treatment in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonVXVW-GkzXLVg90H21EOLACvtfcHk0ljqYJrwQSavdw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXktV2ju78%253D&md5=8e7d55fc6ab2429785a6ba7b62086b91</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F14656566.9.6.913&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656566.9.6.913%26sid%3Dliteratum%253Aachs%26aulast%3DJanko%26aufirst%3DS.%26aulast%3DDorwarth%26aufirst%3DU.%26aulast%3DHoffmann%26aufirst%3DE.%26atitle%3DPharmacotherapy%2520of%2520atrial%2520fibrillation%253A%2520an%2520old%2520option%2520with%2520new%2520possibilities%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2008%26volume%3D9%26spage%3D913%26epage%3D925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Sven, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dierk, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karle, C. A.</span><span> </span><span class="NLM_article-title">The novel antiarrhythmic drug dronedarone: comparison with amiodarone</span> <span class="citation_source-journal">Cardiovasc. Drug Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">217</span><span class="NLM_x">â</span> <span class="NLM_lpage">230</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=217-230&author=K.+Svenauthor=T.+Dierkauthor=C.+A.+Karle&title=The+novel+antiarrhythmic+drug+dronedarone%3A+comparison+with+amiodarone"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSven%26aufirst%3DK.%26aulast%3DDierk%26aufirst%3DT.%26aulast%3DKarle%26aufirst%3DC.%2BA.%26atitle%3DThe%2520novel%2520antiarrhythmic%2520drug%2520dronedarone%253A%2520comparison%2520with%2520amiodarone%26jtitle%3DCardiovasc.%2520Drug%2520Rev.%26date%3D2005%26volume%3D23%26spage%3D217%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Chong, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cory, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yim, B. T.</span><span> </span><span class="NLM_article-title">Treatment of Atrial Fibrillation and Flutter: Focus on Oral Dofetilide, a New Selective Class III Antiarrhythmic Agent</span> <span class="citation_source-journal">HeartDrug</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2001&pages=320-331&author=P.+H.+Chongauthor=F.+Coryauthor=B.+T.+Yim&title=Treatment+of+Atrial+Fibrillation+and+Flutter%3A+Focus+on+Oral+Dofetilide%2C+a+New+Selective+Class+III+Antiarrhythmic+Agent"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChong%26aufirst%3DP.%2BH.%26aulast%3DCory%26aufirst%3DF.%26aulast%3DYim%26aufirst%3DB.%2BT.%26atitle%3DTreatment%2520of%2520Atrial%2520Fibrillation%2520and%2520Flutter%253A%2520Focus%2520on%2520Oral%2520Dofetilide%252C%2520a%2520New%2520Selective%2520Class%2520III%2520Antiarrhythmic%2520Agent%26jtitle%3DHeartDrug%26date%3D2001%26volume%3D1%26spage%3D320%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Page, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nattel, S.</span><span> </span><span class="NLM_article-title">Mechanism of flecainideâs antiarrhythmic action in experimental atrial fibrillation</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">71</span><span class="NLM_x">, </span> <span class="NLM_fpage">271</span><span class="NLM_x">â</span> <span class="NLM_lpage">287</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=1992&pages=271-287&author=Z.+Wangauthor=P.+Pageauthor=S.+Nattel&title=Mechanism+of+flecainide%E2%80%99s+antiarrhythmic+action+in+experimental+atrial+fibrillation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DPage%26aufirst%3DP.%26aulast%3DNattel%26aufirst%3DS.%26atitle%3DMechanism%2520of%2520flecainide%25E2%2580%2599s%2520antiarrhythmic%2520action%2520in%2520experimental%2520atrial%2520fibrillation%26jtitle%3DCirc.%2520Res.%26date%3D1992%26volume%3D71%26spage%3D271%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hohnloser, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van de Loo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baedeker, F.</span><span> </span><span class="NLM_article-title">Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">852</span><span class="NLM_x">â</span> <span class="NLM_lpage">858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1016%2F0735-1097%2895%2900286-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=7560608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADyaK2MXpsVSls7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1995&pages=852-858&author=S.+H.+Hohnloserauthor=A.+van+de+Looauthor=F.+Baedeker&title=Efficacy+and+proarrhythmic+hazards+of+pharmacologic+cardioversion+of+atrial+fibrillation%3A+prospective+comparison+of+sotalol+versus+quinidine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine</span></div><div class="casAuthors">Hohnloser, Stefan H.; van de Loo, Andreas; Baedeker, Frank</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">852-8</span>CODEN:
                <span class="NLM_cas:coden">JACCDI</span>;
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">This study compared the efficacy and safety of sotalol and quinidine for conversion and prevention of recurrent atrial fibrillation.  Atrial fibrillation is the most common arrhythmia.  Pharmacol. therapy has been advocated for both immediate restoration of sinus rhythm and prevention of recurrent atrial fibrillation.  Quinidine is the therapeutic mainstay for both purposes, but its safety has recently been questioned.  Although sotalol has been used successfully to maintain sinus rhythm after d.c. cardioversion, its efficacy in pharmacol. reverting atrial fibrillation has not been examd.  Fifty consecutive patients with persistent atrial fibrillation were randomized to receive quinidine or sotalol for up to 7 days to restore sinus rhythm.  Patients were followed up for 6 mo.  Quinidine was more effective than sotalol in terminating atrial fibrillation (60% vs. 20%, p = 0.009).  When nonresponders to drug therapy underwent subsequent d.c. cardioversion, total conversion rates in the quinidine and sotalol groups were comparable (88% vs. 68%, p = 0.17), as was the efficacy of the two drugs in preventing recurrent atrial fibrillation.  Side effects necessitating drug discontinuation were more often obsd. with quinidine.  No patient receiving sotalol but four patients receiving quinidine had drug-assocd. arrhythmia (torsade de pointes in three patients, sustained ventricular tachycardia in one patient).  Precordial QT dispersion detd. on the surface ECG increased with quinidine (mean Â± SD 34 Â± 9 vs. 44 Â± 16 ms,p = 0.02), indicating enhanced inhomogeneity in ventricular repolarization.  There was no change in QT dispersion in patients receiving sotalol (36 Â± 18 vs. 40 Â± 17 ms, p = 0.44).  Quinidine is more effective than sotalol in terminating atrial fibrillation but is assocd. with more side effects.  The proarrhythmic risk may be related to quinidine's propensity to increase disparity in ventricular repolarization.  This risk warrants careful ECG monitoring during the 1st 4 to 7 days of therapy.  Because most proarrhythmic effects occurred shortly after restoration of sinus rhythm, observation should continue â¥2 to 3 days after sinus rhythm is reestablished.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplSwj57GJs0bVg90H21EOLACvtfcHk0lgf8cgWuHgYow"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXpsVSls7c%253D&md5=8bb6700fea1e5258f4d87acbca0e0b86</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2F0735-1097%2895%2900286-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0735-1097%252895%252900286-5%26sid%3Dliteratum%253Aachs%26aulast%3DHohnloser%26aufirst%3DS.%2BH.%26aulast%3Dvan%2Bde%2BLoo%26aufirst%3DA.%26aulast%3DBaedeker%26aufirst%3DF.%26atitle%3DEfficacy%2520and%2520proarrhythmic%2520hazards%2520of%2520pharmacologic%2520cardioversion%2520of%2520atrial%2520fibrillation%253A%2520prospective%2520comparison%2520of%2520sotalol%2520versus%2520quinidine%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D1995%26volume%3D26%26spage%3D852%26epage%3D858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">De Bruin, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoes, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leufkens, H. G.</span><span> </span><span class="NLM_article-title">QTc-Prolonging Drugs and Hospitalizations for Cardiac Arrhythmias</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">91</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">â</span> <span class="NLM_lpage">62</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2003&pages=59-62&author=M.+L.+De+Bruinauthor=A.+W.+Hoesauthor=H.+G.+Leufkens&title=QTc-Prolonging+Drugs+and+Hospitalizations+for+Cardiac+Arrhythmias"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BBruin%26aufirst%3DM.%2BL.%26aulast%3DHoes%26aufirst%3DA.%2BW.%26aulast%3DLeufkens%26aufirst%3DH.%2BG.%26atitle%3DQTc-Prolonging%2520Drugs%2520and%2520Hospitalizations%2520for%2520Cardiac%2520Arrhythmias%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2003%26volume%3D91%26spage%3D59%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nattel, S.</span><span> </span><span class="NLM_article-title">New ideas about atrial fibrillation 50 years on</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">415</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">â</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=415&publication_year=2002&pages=219-226&author=S.+Nattel&title=New+ideas+about+atrial+fibrillation+50+years+on"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNattel%26aufirst%3DS.%26atitle%3DNew%2520ideas%2520about%2520atrial%2520fibrillation%252050%2520years%2520on%26jtitle%3DNature%26date%3D2002%26volume%3D415%26spage%3D219%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ford, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milnes, J. T.</span><span> </span><span class="NLM_article-title">New Drugs Targeting the Cardiac Ultra-Rapid Delayed-Rectifier Current (IKur): Rationale, Pharmacology and Evidence for Potential Therapeutic Value</span> <span class="citation_source-journal">J. Cardiovasc. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">105</span><span class="NLM_x">â</span> <span class="NLM_lpage">120</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=105-120&issue=2&author=J.+W.+Fordauthor=J.+T.+Milnes&title=New+Drugs+Targeting+the+Cardiac+Ultra-Rapid+Delayed-Rectifier+Current+%28IKur%29%3A+Rationale%2C+Pharmacology+and+Evidence+for+Potential+Therapeutic+Value"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFord%26aufirst%3DJ.%2BW.%26aulast%3DMilnes%26aufirst%3DJ.%2BT.%26atitle%3DNew%2520Drugs%2520Targeting%2520the%2520Cardiac%2520Ultra-Rapid%2520Delayed-Rectifier%2520Current%2520%2528IKur%2529%253A%2520Rationale%252C%2520Pharmacology%2520and%2520Evidence%2520for%2520Potential%2520Therapeutic%2520Value%26jtitle%3DJ.%2520Cardiovasc.%2520Pharmacol.%26date%3D2008%26volume%3D52%26issue%3D2%26spage%3D105%26epage%3D120" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Lloyd, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prol, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandaru, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaccaro, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Dihydropyrazolopyrimidines containing benzimidazoles as KV1.5 potassium channel antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">5469</span><span class="NLM_x">â</span> <span class="NLM_lpage">5473</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5469-5473&issue=18&author=J+Lloydauthor=H.+J.+Finlayauthor=K+Atwalauthor=A+Koverauthor=J+Prolauthor=L+Yanauthor=R+Bhandaruauthor=W+Vaccaroauthor=T+Huynhauthor=C.+S.+Huangauthor=M+Conderauthor=T+Jenkins-Westauthor=H+Sunauthor=D+Liauthor=P.+Levesque&title=Dihydropyrazolopyrimidines+containing+benzimidazoles+as+KV1.5+potassium+channel+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DJ%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DAtwal%26aufirst%3DK%26aulast%3DKover%26aufirst%3DA%26aulast%3DProl%26aufirst%3DJ%26aulast%3DYan%26aufirst%3DL%26aulast%3DBhandaru%26aufirst%3DR%26aulast%3DVaccaro%26aufirst%3DW%26aulast%3DHuynh%26aufirst%3DT%26aulast%3DHuang%26aufirst%3DC.%2BS.%26aulast%3DConder%26aufirst%3DM%26aulast%3DJenkins-West%26aufirst%3DT%26aulast%3DSun%26aufirst%3DH%26aulast%3DLi%26aufirst%3DD%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DDihydropyrazolopyrimidines%2520containing%2520benzimidazoles%2520as%2520KV1.5%2520potassium%2520channel%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26issue%3D18%26spage%3D5469%26epage%3D5473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Lloyd, J</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacarro, W</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyunh, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kover, A</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhandaru, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, D</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective KV1.5 blockers</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">1436</span><span class="NLM_x">â</span> <span class="NLM_lpage">1439</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1436-1439&issue=4&author=J+Lloydauthor=H.+J.+Finlayauthor=W+Vacarroauthor=T+Hyunhauthor=A+Koverauthor=R+Bhandaruauthor=L+Yanauthor=K+Atwalauthor=M+Conderauthor=T+Jenkins-Westauthor=H.+Shiauthor=C+Huangauthor=D+Liauthor=H+Sunauthor=P.+Levesque&title=Pyrrolidine+amides+of+pyrazolodihydropyrimidines+as+potent+and+selective+KV1.5+blockers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLloyd%26aufirst%3DJ%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DVacarro%26aufirst%3DW%26aulast%3DHyunh%26aufirst%3DT%26aulast%3DKover%26aufirst%3DA%26aulast%3DBhandaru%26aufirst%3DR%26aulast%3DYan%26aufirst%3DL%26aulast%3DAtwal%26aufirst%3DK%26aulast%3DConder%26aufirst%3DM%26aulast%3DJenkins-West%26aufirst%3DT%26aulast%3DShi%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DC%26aulast%3DLi%26aufirst%3DD%26aulast%3DSun%26aufirst%3DH%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DPyrrolidine%2520amides%2520of%2520pyrazolodihydropyrimidines%2520as%2520potent%2520and%2520selective%2520KV1.5%2520blockers%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D4%26spage%3D1436%26epage%3D1439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Vacarro, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huynh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lloyd, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finlay, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conder, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins-West, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, L.</span><span> </span><span class="NLM_article-title">Dihydropyrazolopyrimidine inhibitors of KV1.5 (I Kur)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">I18</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">6381</span><span class="NLM_x">â</span> <span class="NLM_lpage">6385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=I18&publication_year=2008&pages=6381-6385&issue=24&author=W.+Vacarroauthor=T.+Huynhauthor=J.+Lloydauthor=K.+S.+Atwalauthor=H.+J.+Finlayauthor=P.+C.+Levesqueauthor=M.+L.+Conderauthor=T.+Jenkins-Westauthor=H.+Shiauthor=L.+Sun&title=Dihydropyrazolopyrimidine+inhibitors+of+KV1.5+%28I+Kur%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVacarro%26aufirst%3DW.%26aulast%3DHuynh%26aufirst%3DT.%26aulast%3DLloyd%26aufirst%3DJ.%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DFinlay%26aufirst%3DH.%2BJ.%26aulast%3DLevesque%26aufirst%3DP.%2BC.%26aulast%3DConder%26aufirst%3DM.%2BL.%26aulast%3DJenkins-West%26aufirst%3DT.%26aulast%3DShi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DL.%26atitle%3DDihydropyrazolopyrimidine%2520inhibitors%2520of%2520KV1.5%2520%2528I%2520Kur%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3DI18%26issue%3D24%26spage%3D6381%26epage%3D6385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Compounds incubated (100 Î¼M) at 37 Â°C for 30 min in 0.1 M potassium phosphate buffer containing 2 mM NADPH, 2 mM dansyl glutathione, and 2 mg/mL human liver microsomes.  The reaction was quenched with 2 volumes of 5 mM dithiothreitol in methanol then vortexed and centrifuged. 60 Î¼L of the supernatant was analyzed by HPLC equipped with a fluorescence detector (Ex = 340 nm, Em = 525 nm).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Treiber, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dansette, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamid, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girault, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginderow, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mornon, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansuy, D.</span><span> </span><span class="NLM_article-title">Chemical and Biological Oxidation of Thiophene: Preparation and Complete Characterization of Thiophene <i>S</i>-Oxide Dimers and Evidence for Thiophene <i>S</i>-Oxide as an Intermediate in Thiophene Metabolism in Vivo and in Vitro</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">1565</span><span class="NLM_x">â</span> <span class="NLM_lpage">1571</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja962466g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=1565-1571&author=A.+Treiberauthor=P.+M.+Dansetteauthor=E.+Hamidauthor=J.-P.+Giraultauthor=D.+Ginderowauthor=J.-P.+Mornonauthor=D.+Mansuy&title=Chemical+and+Biological+Oxidation+of+Thiophene%3A+Preparation+and+Complete+Characterization+of+Thiophene+S-Oxide+Dimers+and+Evidence+for+Thiophene+S-Oxide+as+an+Intermediate+in+Thiophene+Metabolism+in+Vivo+and+in+Vitro"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fja962466g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja962466g%26sid%3Dliteratum%253Aachs%26aulast%3DTreiber%26aufirst%3DA.%26aulast%3DDansette%26aufirst%3DP.%2BM.%26aulast%3DHamid%26aufirst%3DE.%26aulast%3DGirault%26aufirst%3DJ.-P.%26aulast%3DGinderow%26aufirst%3DD.%26aulast%3DMornon%26aufirst%3DJ.-P.%26aulast%3DMansuy%26aufirst%3DD.%26atitle%3DChemical%2520and%2520Biological%2520Oxidation%2520of%2520Thiophene%253A%2520Preparation%2520and%2520Complete%2520Characterization%2520of%2520Thiophene%2520S-Oxide%2520Dimers%2520and%2520Evidence%2520for%2520Thiophene%2520S-Oxide%2520as%2520an%2520Intermediate%2520in%2520Thiophene%2520Metabolism%2520in%2520Vivo%2520and%2520in%2520Vitro%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D1565%26epage%3D1571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Nassar, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez-Anaya, A.</span><span> </span><span class="NLM_article-title">Strategies for dealing with reactive intermediates in drug discovery and development</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">126</span><span class="NLM_x">â</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=14982156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvFOnurs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=126-136&author=A.+F.+Nassarauthor=A.+Lopez-Anaya&title=Strategies+for+dealing+with+reactive+intermediates+in+drug+discovery+and+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Strategies for dealing with reactive intermediates in drug discovery and development</span></div><div class="casAuthors">Nassar, Alaa-Eldin F.; Lopez-Anaya, Arturo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">126-136</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">1367-6733</span>.
    
            (<span class="NLM_cas:orgname">Thomson Scientific</span>)
        </div><div class="casAbstract">A review.  Idiosyncratic drug reactions (IDRs; a specific type of drug toxicity characterized by delayed onset) are a major complication of drug therapy that need to be addressed during drug discovery and development.  Efforts to improve drug safety are hampered by the lack of an accepted approach to predict IDRs, which in turn is due to the low incidence of occurrence of IDRs and the various potential mechanisms involved in these reactions.  The concept of the relative rarity and formation of reactive metabolite of IDRs is briefly described.  Hypothetical chem. mechanisms for the formation of reactive metabolites are summarized, including a classification of adverse drug reactions and types of reactive metabolites.  The relative merits of current and potential strategies for dealing with reactive intermediates in drug discovery and development are examd., and the significance of covalent binding in drug discovery/development in vitro and in vivo systems is considered.  Also discussed are the merits of tools (screening methods to trap reactive intermediates, enzyme inhibition and covalent binding) and strategies for predicting which new drugs have the potential to produce reactive intermediates and IDRs; these approaches may be considered to have the potential to improve the overall safety profile of drug candidates at various stages of the drug discovery and development process.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkBgR4sVvEtLVg90H21EOLACvtfcHk0lg1UmPRn52YQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvFOnurs%253D&md5=b1164d34fe9c7d1dd4d0e6c5063b6974</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNassar%26aufirst%3DA.%2BF.%26aulast%3DLopez-Anaya%26aufirst%3DA.%26atitle%3DStrategies%2520for%2520dealing%2520with%2520reactive%2520intermediates%2520in%2520drug%2520discovery%2520and%2520development%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2004%26volume%3D7%26spage%3D126%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Reimlinger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Overstraeten, A.</span><span> </span><span class="NLM_article-title">Reactions of 3(5)-diazopyrazole. II</span> <span class="citation_source-journal">Chem. Ber.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">3350</span><span class="NLM_x">â</span> <span class="NLM_lpage">3357</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1966&pages=3350-3357&author=H.+Reimlingerauthor=A.+Van+Overstraeten&title=Reactions+of+3%285%29-diazopyrazole.+II"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReimlinger%26aufirst%3DH.%26aulast%3DVan%2BOverstraeten%26aufirst%3DA.%26atitle%3DReactions%2520of%25203%25285%2529-diazopyrazole.%2520II%26jtitle%3DChem.%2520Ber.%26date%3D1966%26volume%3D99%26spage%3D3350%26epage%3D3357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Kirk, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. A.</span><span> </span><span class="NLM_article-title">Photochemistry of diazonium salts. I. Synthesis of 4-fluoroimidazoles, 4-fluorohistamine, and 4-fluorohistidine</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">4619</span><span class="NLM_x">â</span> <span class="NLM_lpage">4624</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja00795a026" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1973&pages=4619-4624&author=K.+L.+Kirkauthor=L.+A.+Cohen&title=Photochemistry+of+diazonium+salts.+I.+Synthesis+of+4-fluoroimidazoles%2C+4-fluorohistamine%2C+and+4-fluorohistidine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fja00795a026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja00795a026%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DCohen%26aufirst%3DL.%2BA.%26atitle%3DPhotochemistry%2520of%2520diazonium%2520salts.%2520I.%2520Synthesis%2520of%25204-fluoroimidazoles%252C%25204-fluorohistamine%252C%2520and%25204-fluorohistidine%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1973%26volume%3D95%26spage%3D4619%26epage%3D4624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Janssen, J. W. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeners, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kruse, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Habraken, C. L.</span><span> </span><span class="NLM_article-title">Pyrazoles. XII. Preparation of 3(5)-nitropyrazoles by thermal rearrangement of <i>N</i>-nitropyrazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1777</span><span class="NLM_x">â</span> <span class="NLM_lpage">1782</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00950a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1973&pages=1777-1782&author=J.+W.+A.+M.+Janssenauthor=H.+J.+Koenersauthor=C.+G.+Kruseauthor=C.+L.+Habraken&title=Pyrazoles.+XII.+Preparation+of+3%285%29-nitropyrazoles+by+thermal+rearrangement+of+N-nitropyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjo00950a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00950a001%26sid%3Dliteratum%253Aachs%26aulast%3DJanssen%26aufirst%3DJ.%2BW.%2BA.%2BM.%26aulast%3DKoeners%26aufirst%3DH.%2BJ.%26aulast%3DKruse%26aufirst%3DC.%2BG.%26aulast%3DHabraken%26aufirst%3DC.%2BL.%26atitle%3DPyrazoles.%2520XII.%2520Preparation%2520of%25203%25285%2529-nitropyrazoles%2520by%2520thermal%2520rearrangement%2520of%2520N-nitropyrazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1973%26volume%3D38%26spage%3D1777%26epage%3D1782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wasicak, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebold, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hettinger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrera, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holladay, M. W.</span><span> </span><span class="NLM_article-title">Ligands for Brain Cholinergic Channel Receptors: Synthesis and in Vitro Characterization of Novel Isoxazoles and Isothiazoles as Bioisosteric Replacements for the Pyridine Ring in Nicotine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">4455</span><span class="NLM_x">â</span> <span class="NLM_lpage">4463</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00052a005" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1994&pages=4455-4463&issue=26&author=D.+S.+Garveyauthor=J.+T.+Wasicakauthor=R.+L.+Elliottauthor=S.+Leboldauthor=A.+Hettingerauthor=G.+M.+Carreraauthor=N.+Linauthor=Y.+Heauthor=M.+W.+Holladay&title=Ligands+for+Brain+Cholinergic+Channel+Receptors%3A+Synthesis+and+in+Vitro+Characterization+of+Novel+Isoxazoles+and+Isothiazoles+as+Bioisosteric+Replacements+for+the+Pyridine+Ring+in+Nicotine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm00052a005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00052a005%26sid%3Dliteratum%253Aachs%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DWasicak%26aufirst%3DJ.%2BT.%26aulast%3DElliott%26aufirst%3DR.%2BL.%26aulast%3DLebold%26aufirst%3DS.%26aulast%3DHettinger%26aufirst%3DA.%26aulast%3DCarrera%26aufirst%3DG.%2BM.%26aulast%3DLin%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DY.%26aulast%3DHolladay%26aufirst%3DM.%2BW.%26atitle%3DLigands%2520for%2520Brain%2520Cholinergic%2520Channel%2520Receptors%253A%2520Synthesis%2520and%2520in%2520Vitro%2520Characterization%2520of%2520Novel%2520Isoxazoles%2520and%2520Isothiazoles%2520as%2520Bioisosteric%2520Replacements%2520for%2520the%2520Pyridine%2520Ring%2520in%2520Nicotine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1994%26volume%3D37%26issue%3D26%26spage%3D4455%26epage%3D4463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Synders, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamakun, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, P. B.</span><span> </span><span class="NLM_article-title">A rapidly activating and slowly inactivating potassium channel cloned from human heart: functional analysis after stable mammalian cell culture expression</span> <span class="citation_source-journal">J. Gen. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">543</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=1993&pages=513-543&author=D.+J.+Syndersauthor=M.+N.+Tamakunauthor=P.+B.+Bennett&title=A+rapidly+activating+and+slowly+inactivating+potassium+channel+cloned+from+human+heart%3A+functional+analysis+after+stable+mammalian+cell+culture+expression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSynders%26aufirst%3DD.%2BJ.%26aulast%3DTamakun%26aufirst%3DM.%2BN.%26aulast%3DBennett%26aufirst%3DP.%2BB.%26atitle%3DA%2520rapidly%2520activating%2520and%2520slowly%2520inactivating%2520potassium%2520channel%2520cloned%2520from%2520human%2520heart%253A%2520functional%2520analysis%2520after%2520stable%2520mammalian%2520cell%2520culture%2520expression%26jtitle%3DJ.%2520Gen.%2520Physiol.%26date%3D1993%26volume%3D101%26spage%3D513%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Zhou, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vorperian, V. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span> </span><span class="NLM_article-title">and January, C.T. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole</span> <span class="citation_source-journal">J. Cardiovasc. Electrophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">836</span><span class="NLM_x">â</span> <span class="NLM_lpage">843</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1999&pages=836-843&issue=6&author=Z.+Zhouauthor=V.+R.+Vorperianauthor=Q.+Gongauthor=S.+Zhang&title=and+January%2C+C.T.+Block+of+HERG+potassium+channels+by+the+antihistamine+astemizole+and+its+metabolites+desmethylastemizole+and+norastemizole"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DZ.%26aulast%3DVorperian%26aufirst%3DV.%2BR.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DS.%26atitle%3Dand%2520January%252C%2520C.T.%2520Block%2520of%2520HERG%2520potassium%2520channels%2520by%2520the%2520antihistamine%2520astemizole%2520and%2520its%2520metabolites%2520desmethylastemizole%2520and%2520norastemizole%26jtitle%3DJ.%2520Cardiovasc.%2520Electrophysiol.%26date%3D1999%26volume%3D10%26issue%3D6%26spage%3D836%26epage%3D843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Li, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levesque, P.</span><span> </span><span class="NLM_article-title">Antiarrhythmic drug therapy for atrial fibrillation: focus on atrial selectivity and safety</span> <span class="citation_source-journal">Cardiovasc. Hematol. Agents Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">64</span><span class="NLM_x">â</span> <span class="NLM_lpage">75</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2009&pages=64-75&issue=1&author=D.+Liauthor=H.+Sunauthor=P.+Levesque&title=Antiarrhythmic+drug+therapy+for+atrial+fibrillation%3A+focus+on+atrial+selectivity+and+safety"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DD.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLevesque%26aufirst%3DP.%26atitle%3DAntiarrhythmic%2520drug%2520therapy%2520for%2520atrial%2520fibrillation%253A%2520focus%2520on%2520atrial%2520selectivity%2520and%2520safety%26jtitle%3DCardiovasc.%2520Hematol.%2520Agents%2520Med.%2520Chem.%26date%3D2009%26volume%3D7%26issue%3D1%26spage%3D64%26epage%3D75" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Carlsson, Leif.</span><span> </span><span class="NLM_article-title">The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">160</span><span class="NLM_x">â</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm201386u&amp;key=10.1016%2Fj.pharmthera.2008.04.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm201386u&amp;key=18558435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm201386u&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVKntrnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=2008&pages=160-167&issue=2&author=Leif.+Carlsson&title=The+anaesthetised+methoxamine-sensitised+rabbit+model+of+torsades+de+pointes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">The anaesthetised methoxamine-sensitised rabbit model of torsades de pointes</span></div><div class="casAuthors">Carlsson, Leif</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">160-167</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Current guidelines describe strategies on how the potential of non-antiarrhythmic drugs to delay ventricular repolarisation should be assessed.  However, the non-clin. guidelines recommend repolarisation assays only and do not advocate exptl. models that express the proarrhythmia of concern, torsades de pointes (TdP).  Although the repolarisation assays may predict QT interval prolongation in man they cannot alone sufficiently predict proarrhythmia risk.  Furthermore, there is also a need for more robust surrogate markers of drug-induced proarrhythmia and such validated markers are on the horizon as a result of the availability of sensitive animal models of TdP.  This review will describe the methoxamine-sensitized rabbit model of TdP, one of the most frequently used proarrhythmia models, and present some of it characteristics, its pros and cons and how it historically has been used for assessing proarrhythmia liability of drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxUJSRwevXy7Vg90H21EOLACvtfcHk0lgkkCsf0KHcQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVKntrnE&md5=80b12489e03cb25cafb3417768d0e0d6</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2008.04.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2008.04.004%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DLeif.%26atitle%3DThe%2520anaesthetised%2520methoxamine-sensitised%2520rabbit%2520model%2520of%2520torsades%2520de%2520pointes%26jtitle%3DPharmacol.%2520Ther.%26date%3D2008%26volume%3D119%26issue%3D2%26spage%3D160%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-99"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i40"><a href="/doi/suppl/10.1021/jm201386u">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_87208"></div></div></div></div></div><hr /></hr><p class="last">Absolute stereochemistry at the C7 position confirmed by the X-ray structure. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm201386u/suppl_file/jm201386u_si_001.mol">jm201386u_si_001.mol (8.85 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm201386u&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-7%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm201386u%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm201386u" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                817KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992b717f17d193","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
